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RESUME 
11 
Vers la fin de l'année 2004, la population porc me canadienne a connu une 
recrudescence marquée du syndrome de dépérissement en post-severage (SDPS), problème 
que l'on avait associé à l'émergence d'un nouveau génotype de Circovirus porcin de type 2 
(PCV -2b) jusque là inconnu en Amérique du Nord. Ainsi, il est devenu important de 
démontrer que la souche de PCV -2b circulant dans les élevages porcins canadiens est plus 
virulente que l'ancienne souche (PCV-2a). Des clones plasmidiques infectieux de l'ancien 
génotype (PCV-2a) et du nouveau génotype (PCV-2b) viral ont été conçus (pPCV-2a et 
pPCV-2b). L'efficacité de la lignée cellulaire épithéliale porcine de rein (PK-15) 
tr~sfectée par pPCV -2a et par pPCV -2b a permis un cycle complet de réplication virale. 
Par la suite, la production de particules infec~ieuses de PCV -2 a été évaluée durant hùit 
passages cellulaires consécutifs. Ainsi, dix fois plus de particules virales infectieuses de 
PCV-2b ont été recueillies au 8e passage par rapport au PCV.;.2a. Plus tard la lignée 
cellulaire épithéliale trachéale de porcelets nouveau-nés (NPTr) s'est révélée comme étant 
permissive au PCV -2 et pouvant par conséquent permettre la production de particules 
virales infectieuses. Cette découverte est très importante car jusqu'à maintenant, il n'y avait, 
à notre connaissance, qu'un seul type de lignée cellulaire immortalisée (cellules épithéliales 
porcines de rein) qui permet la production de particules virales infectieuses, suite à 
l'infection virale. 
Donc, pour corroborer les résultats précédents, les cinétiques de réplication virale de 
PCV-2 ont été évaluées chez les cellules PK-15 et NPTr: La cinétique de réplication virale 
de PCV-2b s'est montrée considérablement plus efficace que celle de PCV-2a dans les 
deux lignées cellulaires. Aucune différence significative par rapport à l'efficacité de la 
réplicati.on virale n'a été observée entre les deux lignées cellulaires. En conclusion, PCV -2b 
est approximativement 6 à 10 fois plus efficace que PCV -2a pour la synthèse de particules 
virales infectieuses' dans deux lignées cellulaires épithéliales porcines. De plus, la lignée 
cellulaire NPTr pourrait servir en guise de nouveau modèle in vitro I?our l'étude de la 
pathogénèse du PCV-2. Pai conséquent, l'efficacité de réplication virale de PCV .. 2b en 
comparaison à celle de PCV-2a pourrait, au moins en partie, justifier la recrudescence 
marquée du SDPS au Canada au cours des dernières années. 
MOTS CLÉS: SDPS, cellules NPTr, réplication virale, génotypes de PCV -2, circovirus 
porcin. 
ABSTRACT 
• 
IV 
By the end of 2004, the Canadian swine population had experienced a severe 
increase in the incidence of Porcine Circovirus-Associated Disease (PCV AD), a problem 
that was associated with the emergence of a new Porcine circovirus-2 genotype (PCV -2b) 
previously unknown in North America. Thus, it became important to demonstrate that the 
PCV -2b strain circulating in Canadian swine herds is more virulent than the older PCV -2a 
strain. ·Infectious DNA clones of PCV -2a and PCV -2b were constructed (pP CV -2a and 
pPCV-2b). The efficacy of pPCV-2a and pPCV-2b transfected porcine kidney epithelial 
cell line (PK-15) to allow a complete virus replication cycle and production of PCV-2 
infectious particles was evaluated during eight consecutive cell passages. Ten times more 
PCV -2b infectious viral particles were recovered at the 8th cell passage compared to PCV-
2a. Later on, a new porcine cellline, the newbom piglet tracheal(NPTr) epithelial cellline, 
was found to be permissive to PCV -2 and was consequently able to permit infectious viral 
particles production. This finding is interesting because until now, there was only one type 
of immortalized cell line (the porcine kidney epithelial ce Ils) known to permit infectious 
viral particles production. 
Thus, to corroborate early results, the PCV -2a and PCV -2b replication kinetics were 
evaluated in PK-15 and NPTr cells. PCV-2b virus replication kinetic was significantly 
more efficient in both cell lines compared to PCV -2a. No differences in virus replication 
efficiency could be found between both cell lines. In conclusion, PCV -2b is about 6 to 10 
times more efficient than the PCV -2a for the synthesis of infectious viral particles in two 
porcine epithelial celllines. Moreover, the NPTr ceIlline could be used as a new in vitro 
model for studying the PCV-2 pathogenesis. Consequently, the virus replication efficiency 
of PCV -2b compared to PCV -2a could, at least in part, explain the increase in the 
occurrence of PCV AD in Canada during the recent years. 
KEYWORDS: PMWS, NPTr cell~, virus replication, PCV -2 genotypes, porcine circovirus 
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1. INTRODUCTION 
2 
Postweaning Multisystemic Wasting Syndrome (PMWS) is a swine disease, that was 
first recognized in Canada in 1991 [39, Tl]. Afterwards, the syndrome was reported 
worldwide [8, 10,24, 128, 147, 151]. The primary etiological agent responsible for PMWS 
has been identified as a circovirus named Porcine circovirus-2 (PCV -2; family 
Circoviridae, genus Circovirus) [8, 52, 70, 106]. 
At the end of 2004, the swine industry In the prOVInce of Québec, Canada, 
experienced a significant increase in death rate related to PMWS [42]. It was hypothesized 
that this emerging problem was caused by the presence of a new type of circulating PCV-2 
strain. This was confirmed by sequencing the entire viral genome of several PCV -2 strains 
originated from PMWS-affected herds [63]. Interestingly, this newly recovered PCV-2 
genotype (named PCV -2b in comparison with the previously circulating genotype named 
PCV -2a) had, already been reported in Asia and Europe [46] and has also, been recently 
reported in 2007 in the United States [34, 79]. The appearance of the new PCV -2b 
genotype in Canada could explain the death rate increase related to PMWS, but this 
relationship has to be confirmed. Consequently, one of the main objectives of the swine 
industry and health scientists is to establish if there is a virulence variation between both 
PCV-2 genotypes (PCV-2a and PCV-2b). 
The pathogenesis ofPCV-2 infection and major cell types that support PCV-
2 replication are poorly understood. The presence of a PCV -2 antigen and nuc1eic acids has 
,been shown in different cell types in vivo by immunohistochemistry (IHC) or in situ 
hybridization (ISH). In vitro, the only immortalized ceIlline that support PCV -2 replication 
is porcine kidney epithelial cells [10, 106, 111, 142], and PCV-2 isolation and production is 
routinely performed using porcine kidney (PK-15) and swine kidney (SK) epithelial cell 
lines [10, 142]. Nonetheless, it is a good assumption to believe that kidney cells are not the 
first infected cells that favor propagation of the virus in theorganism. The oro-nasal route is 
considered the most likely and frequent route of PCV -2 transmission and experimental 
infection studies which have mainly used the intranasal route of inoculation support that 
idea [16, 53, 85, 128, 142]. 
Consequently, the goal of the present study is therefore: (l) to demonstrate that the 
PCV -2b strain that circulates inCanadian swine herds is more virulent in vitro and in vivo 
than the PCV -2a strain; (2) to establish if epithelial cells of the respiratory tract of swine 
3 
could support PCV -2 replication in vitro, and (3) to develop a diagnostic test that could 
rapidly and efficiently differentiate both genotypes. 
II. LITERATURE REVIEW 
5 
POSTWEANING MULTISYSTEMIC WASTING SYNDROM - PMWS 
1. History and definition 
Postweaning Multisystemie Wasting Syndrome (PMWS) is a swine disease that was 
first reeognized in Canada in 1991 [39, 71]. Afterwards, the syndrome was reported 
worldwide [3, 10,24, 128, 147, 151]. The primary etiologieal agent résponsible for PMWS 
has been identified as a eireovirus named Porcine circovirus-2 (PCV -2; family 
Circoviridae, genus Circovirus) [70]. 
PMWS is considered a multifactorial disease in pigs, in which a necessary factor 
is the presence of PCV -2. Since PCV -2 is ubiquitous in the pig population and infection 
doesn't equate to disease, a definition for PMWS was proposed [158]. Based on this 
definition, a diagnosis of PMWS requires (1) the presence of clinical signs such as 
wasting, weight loss and respiratory disease, (2) the presence of the hall mark PCV -2-
associated microscopic les ions (lymphoid depletion and/or histiocytic replacement of 
follicles in lymphoid tissues or both), and (3) PCV -2 antigen or nucleic acids associated 
with the microscopie lesions as determined by immunohistoehemistry (IRC) or in situ 
hybridization (ISR) [158]. 
2. Disease terminology 
Today, the clinical expression of PCV-2 infection in swine is acknowledged to be 
. more eomplex than initially established because it ean play a pivotaI role in several 
syndromes, such as Porcine Dermatitis and Nephropathy Syndrome (PDNS), Porcine 
Respiratory Disease Complex (PRDC), granulomatous enteritis, reproductive failure and 
necrotizing lymphadenitis [25, 72]. In addition, PCV-2 has also been associated with· 
myocarditis and vasculitis in growing pigs, hepatitis, CNS disease, and exudative 
, ' 
epidermitis [25, 72, 128].· Consequently, the term "porcine circovirus associated disease 
6 
(PCV AD)" is now accepted to describe the syndromes in which PCV -2 plays a role. The 
extent of the involvement of PCV -2 in swine diseases other than PMWS is currently po orly 
understood. PCV -2 infection is widespread and essentially aIl pig herds are infected with 
PCV -2 but relatively few have PCVAD. 
3. Postweaning Multisystemic Wasting Syndrome - PMWS 
The disease usually affects 5 to 12 week-old piglets and is characterized in part by 
weight loss, dyspnea, jaundice, and enlarged lymph nodes, as weIl as by degeneration and 
necrosis of hepatocytes, multifocal lymphohistiocytic pneumonia, lymphocytic depletion 
andmultinucleated giant cell formation [71,·158]. Depletion of lymphocytes in the 
lymphoid follicles and their replacement by macrophages are the hallmark lesions observed 
. . 
in this syndrome [10, 106]. PMWS has six fundamental clinical signs: wasting, dyspnea, 
enlarged lymph nodes, diarrhea, paIlor, and jaundice [72]. While aIl the fundamental 
clinical signs may not be noted in a single pig, affected farms will present the majority of 
them over a period of time. Other clinical signs include coughing, fever,gastric ulceration, 
meningitis and sudden death [72]. Macroscopic lesions associated with PCV-2 infection 
include generalized lymphadenopathy, rubbery lungs with mottling and increased firmness, 
enlarged spleen and enlarged kidneys [39].· Characteristic microscopic lesions associated 
with PCV -2 infection and PMWS include lymphoid depletion and histiocytic replacement 
of follicles in lymphoid tissues. The lymphocellular depletion affects both lymphoid 
follicles and parafollicular zones [140]. Mild-to-severe granulomatous inflammation in 
lymphoid and other tissues also is commonly observed [11, 158]. Syncytial cells can be 
,. 
seen frequently, especially in lymph nodes, Peyer' s patches and lamina propria of the 
intestinal villi [140]. Macrophages in affected lymphoid tissues may contain sharply 
demarcated, spherical, basophilic cytoplasmic inclusion bodies [39, 140]. The inclusions 
are either large and single or smaller and multiple with groups ofup to 12 'inclusions [140]. 
PMWS has been reported from almost aIl swine producing countries. Morbidity due 
to PMWS reportedly varies from as little as 4% to as high as 30% and mortality in aÎfected 
. pigs is typically 70 to 80% [11, 39, 71, 99, 139]. There are two forms of PMWS: an 
7 
endemic and an epidemic form. The endemic form is seen in North America, where PMWS 
usually results in low grade but persistent death losses. Rarely, 3 to 4 fold increase in 
postweaning mortality can be observed. The epidemic form, which is characterized by 
persistent mortality, appeared to be observed primarily in Europe but based on recent 
evidence, has become increasingly observed in eastem Canada [22, 23, 42, 47, 63] and 
North Carolina. Pork pro duc ers in Canada and the U.S. have experienced a devastating 
disease in growing pigs which is manifested as wasting and pneumonia and resulting in 
persistent mortality of 20-40% of the pigs between 10 weeks and market age (25 weeks) 
[128]. 
4. Porcine Dermatitis and Nephropathy Syndrome - PDNS 
PDNS is c1inically characterized by acute onset of skin lesions (raised purple skin 
lesions progressing to multifocal raised red scabs with black centers most prominent on the 
rear legs), fever and lethargy, and is almost always fatal [25]. Macroscopically, there are 
enlarged tan waxy kidneys with white foci and streaks [25]. Microscopically, there is 
systemic vasculitis with dermal and epidermal necrosis, and necrotizing and fibrinous 
glomerulonephritis [25]. The microscopic hallmark lesions of PDNS, generalized vasculitis 
and glomerulonephritis, are suggestive of a type III hypersensitivity reaction which is 
characterized by deposition of antigen-antibody aggregates or immune complexes on 
certain tissue sites [36, 141, 159]. 
There are two forms of PDNS described: the sporadic form and the epizootic form . 
. With the sporadic form, the mortality is rarely above 0.5%. The epizootic form was first 
observed in 1999 in England, when there was a sudden, marked increase of PDNS cases 
[160, 161]. The within-herd mortality was reported to range from 0.25-20% and similar 
observations were made in the Netherlands [51,171] . Investigations into this "outbreak" 
found that there was a c1ear temporal association of PMWS and PDNS; PDNS cases 
usually followed PMWS cases on the same farms. Studies have determined that the mean 
age of pigs affected by PMWS ranges from 6 to 14 weeks whereas the mean age of pigs 
affected by PDNS ranges from 12 to 16 weeks [69]. Similar observations were made in 
8 
Korea [37], and the authors of that study speculated that the presence of both PMWS and 
PDNS in the same herd but in different age groups was probably due to different strains of 
PCV -2 or varying susceptibility of the pigs [37]. A recent case:-control study irivestigating 
PDNS in the Netherlands found that there was a significant association of high antibody 
titers to PCV-2 and the development ofPDNS [171]. Thè authors were not able to show the 
PCV -2 antigen by IHC in aIl of the PDNS cases but they were a~le to confirm the presence 
of PCV -2 by polyrp.erase chain reaction (PCR) in aIl cases of PDNS. Importantly, the 
authors were able to show that the, porcine parvovirus or Porcine Reproductive and 
Respiratory Syndrome Virus (PRRSV) nucleic acids were not present in many of the PDNS 
cases as determined by PCR [171]. A study comparing PCV-2 serum load in PMWS and 
PDNS cases found that PDNS cases had significantly lower numbers of PCV -2 in serum 
compared to healthy, subclinical PCV-2-infected pigs [119]. 
9 
PORCINE CIRCOVIRUS TYPE 2 
1. History 
Porcine circovirus (PCV) was first recognized as a contaminant of the continuous 
porcine kidney cell line (PK-15) (ATCC-CCL31) in 1974 in Germany and described as 
picomavirus-like virus [163]. Under experimental conditions, the PCV-PKI5-isolate did 
'not induce dise~se in pigs [7, 164]. In the late 1990's, PCV was associated with a newly-
emerged disease syndrome in pigs, described as "postweaning multisystemic wasting 
syndrome" (PMWS) [3]. Sequence analysis of the PMWS-associated PCV revealed 
differences compared to the earlier described PCV [3, 8, 10, 52, 70, 106, 114]. In order to 
distinguish the pathogehic PMWS-associated PCV from the non-pathogenic PCV, the 
pathogenic type was designated porcine circovirus type 2 (PCV -2) and the non-pathogenic 
type as porcine circovirus type 1 (PCV -1). 
2. Taxonomy 
Both, PCV-l and PCV-2' are members of the Cireoviridae family [135, 168]. The 
Cireoviridae family is divided into the genera Cireovirus [Cireo indicates that the genome 
, of the virus has a circular conformation] and Gyrovirus [Gyro is a derivation from the 
Greek work "gyrus" meaning "ring" or "circuit"] (Fig. 1). The genus Cireovirus contains 
the following species: psittacine beak and feather disease virus (BFDV), canary circovirus 
(CaCV), goose circovirus (GoCV), pigeon circovirus (PiCV), PCV -1 and PCV -2 [77, 131, 
137, 166-168]. The species tentatively placed in the genus Cireovirus are duck circovirus 
(DuCV), finch circovirus (FiCV), and gull circovirus (GuCV) (Fig. 1). The genus 
Gyrovirus contains only one virus, the chicken: anemia virus (CA V) [168] (Fig. 1). 
ICircovirus 1 
Circoviridae 
• Beakalid.'feather disease'virus, BFDV 
• CilBary cirtovirus, CaCV 
) • Goo,se,circovirus,GoCV 
--~ • Pigeon cïrcovirus, PiCV 
• Porcine &:ÏJ'qJvÏruS -1, RCV4 
• Porcine circovirus -2, PCV-2 
1 Gyrovirus I----)~ I·Chicken anemia virus, CAV 
Figure 1. Circoviridae family classification. 
3. Characterization ·of PCV-2 
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Viruses that belong to the Circoviridae family have characteristic Vlflons that 
exhibit icosahedral symmetry and do not posses an envelope. The genomes are covalently 
closed, circularsingle-stranded (ss) DNAs, which range in size from 1.7 to 2.3 kb. The 
genome organization of CA V is negative sense, whereas those of the other circoviruses are 
ambisense [1681. CAV, PCV-2, and BFDV were found to have an icosahedral T=1 
structure containing 60 capsid protein molecules arranged in 12 pentamer clustered units 
[41]. Circoviruses are host-specific or exhibit a narrow host range and the majority ofthose 
reported' infect avian species [168]. Subclinical infections are common; however, circovirus 
infections are associated with clinical disease insome cases such as Chicken Anemia Virus, 
psittacine BFDV, PiCV disease and PCVAD in pigs. Circovirus infections in all species 
cause varying degrees of lymphoid depletion and are thought to be immunosuppressive 
[168]. 
PCV are among the smallest known mammalian viruses with a diameter of around 
17 nm [164]. It is composed of coat protein subunits assembled in 12 pentameric units [41]. 
The genome of PCV-l and PCV-2 share 68-76% nt-sequence similarity [105], whereas 
PCV-l and PCV-2 iI1tragenotype isolates share 97-99 and 94.6-99% sequence identity, 
respectively [46, 55]. PCV-2 genome contains three main open reading frames (ORFs) 
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(Fig. 2), whieh are the ORFI (nt 398-1342) eneoding the repliease protein (Rep); the ORF2 
(nt 1381-314) encoding the immunogenic capsid protein (Cap); and the new1y characterized 
protein encoded by ORF3 (nt 1018-704) which appears to contribute tovi.rus-induced 
apoptosis of host infected eeUs [32, 33, 95, 104, 116]. The nucleotide positions refer to 
those on the putative virus encapsidated genomic ssDNA, and a schematic representation of 
.. the positions of the se ORFs is shown in Fig 2. The intra-type amino acid homology 
between the Reps of PCV-I and PCV-2 is approximately 99.4 and 95.7%, respectively, 
while the intra-type amino acid homology between the capsid proteins of PCV -1 and PCV-
2 is94 and 90%, respectively [55]. Thus, the capsid genes exhibit more sequence 
divergence than the Rep genes. In addition to ORF1, ORF2, and ORF3; it is predicted that 
there are another four potential ORFs (Fig. 2) encoding proteins larger than 5kDa [106]. 
~> IORF61' 
~<// 
ORFI ~.~/ 
(Rep prot) 
Viral DNA 'Complelllentaty strand 
Figure 2. PCV genome organization: overlapping and ambissence ORFs. Adapted from 
Meehan et al. (1998). 
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identity for the capsid protein. One strain identified in a herd without PMWS was found to 
be 100.0% homologous to a PCV -2 from a PMWS herd. [92]. In 2004, 31 pigs originating 
from 13 PMWS-affected herds and 25 pigs from 10 PMWS free herds were used for a 
comparative study, and 38 PCV-2 isolates were sequenced [46]. AlI the isolates shared 
94.2-100% nucleotide identity. A wider nucleotide diversity was observed in the PCV-2 
isolates originating from PMWS free herds compared with isolates from PMWS herds; 
however, residues found to be specific to non-PMWS strains were aiso found in PMWS 
strains and no molecular marker of virulence in PMWS strains could be identified [46]. In a 
. case control study done in 2002, PCV -2 was not only found in PMWS cases but also in 
62.5% of the control cases. Sequencing and genetic comparison revealed no differences 
between 5 PMWS-associated PCV -2 isolates and 4 PCV -2 isol'l-tes recovered from cases 
not associated with PMWS [133]. 
In contrast, by comparing the ORF2 of Taiwanese PCV-2 isolates associated with 
PMWS, PDNS, nervous signs, abortion, a small number of residue difference associated 
with the different clinical conditions was found [170]. Research on the construction and 
characterization of 2 chimeric infectious DNA clones of PCV-l and PCV-2 has provided 
further insight into the virus virulence factors [59]. The chimeric PCV-I-2 DNA clone 
contained the PCV -2 capsid gene cloned in the backbone of the non-pathogenic PCV -1. 
The chimeric PCV -1-2 virus induced a strong and specific antibody response to the 
pathogenic PCV -2 capsid antigen and was attenuated (minimal to no lesions, low level and 
reduced length of viremia, low or nondetectable levels of viral antigen in lymphoid tissues) 
when inoculated into pigs [59]. In another study, two amino acid mutations occurred in the 
capsid prote in ofPCV-2 after 120 seriaI passages in cell culture and resulted in attenuation 
of the virus in vivo [58]. Significant differences were observed in the PCV -2 genomic copy 
numbers in serum, and the gross and microscopic lesions in pigs inoculated with the wild-
type PCV isolate were more severe.than those inoculated with the passage 120 PCV-2 
isolate [58]. This study confinrted that minimal changes in the genome of a PCV-2 isolate 
can markedly alter the virulence of PCV -2 viruses. Possible differences in virulence' among 
Midwestern US field isolates of PCV-2 with 98.9% nucleic acid and 96.7% amino acid 
sequence identities in ORF2 were investigated in an in vivo study reported in 2006 [127]. 
The in vivo study using SPF pigs confirmed that PCV -2 isolates with minimal genomic 
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Figure 3. Phylogenetic analysis of the complete genome of porcine circovirus 2 (PCV -2) 
strains. An unrooted neighbor-joining tree was constructed from aligned nucleic acid 
sequences of 27 Canadian reference strains (including the newly described 13 sequences 
identified with an arrow and the oIder sequences identified with an asterix) and 43 
sequences found in GenBank. Taken from Gagnon et al. (2007). 
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4. Biologie. and Physical Properties 
PCV-l is stable at pH 3, at 56°C and at 70°C for 15 minutes, and is resistant to 
inactivation after exposure to chloroform [6]. The buoyant density of PCV-l in CsCI is 
1.37 g per cm3 [163], and it is 1.36-1.37 g per ml CsCI [6]. The sedimentation coefficient 
(S) was determined to be 57S when compared with the sedimentation coefficient of a 
bovine enterovirus [6]. 
PCV -2 is readily isolated from tissue samples that have been stored at -70°C [52]. 
PCV-2 was shown to be resistant to sorne disinfectants (Nolvasan®, DC&R®, Weladol®, 
s 
or ethanol) but virus tÏiers were significantly reduced by sodium hydroxide, Virkon® S, 
and others [143]. 
5. Replication and Mechanisms of Virus Entry into the CeUs 
AIl viruses of the Circoviridae family are thought to have a similar replication 
strategy. A circular, double stranded replicative form of DNA intermediate is produced 
using host cell DNA polymerases during the S phase of cell division [165, 168]. The 
r~plicative form serves as template for generation of viral ssDNA using the rolling circle 
replication mechanism [168]. Viral DNA intermediates are generated in the nuclei and 
require host cell enzymes for completion of the replication cycle [165]. Virions are 
assembled in both nuclei and cytoplasm and released from infected cells in the absence of 
vir\il cytopathic effects. 
Other authors studied the binding characteristics of PCV -2. In the porcme 
monocytic line 3D4/31, PCV-2 enters predominantly via clathrin-mediated endocytosis and 
requires an acidic environrrient for infection [110]. The PCV -2 capsid protein is expressed 
between 6 to 12 hours post inoculation and nuclear relocation occurred around 12 to 24 
hours post inoculation in PK-15 cells. In porcine alveolar macrophages or fetal 
cardiomyocytes, nuclear localized antigens appeared approximately at 48 hours post 
inoculation and in fewer cells [108]. Treatment of PK -15 cell cultures with IFN -1 causes a 
20 times higher production of PCV -2 progeny [109]. The enhancing effect of interferon-
13 
gamma (IFN-y) on PCV-2 infeétion was found to be due to increased internalization of 
PCV -2 virion-like particles. Expressions of PCV -2 proteins in infected cells were not 
altered by IFN-y treatment [109]. 
During productive infection ofPK-15 cells, nine mRNA as capsid RNA, five Rep-
associated RNAs (Rep, Rep', Rep3a, Rep3b, and Rep3c), and three NS-associated RNAs 
(NS515, NS672, and NSO) are synthesized by PCV -2 [32]. It was demonstrated that Rep and 
Rep' are essential for PCV-2 replication [33]. PCV-l and PCV-2 were found to differ from 
each other in expression levels ofNS and Rep3c-associated RNAs [31]. 
6. PCV -2 isolates 
6.1. PCV -2 genetic variation 
Molecular studies to determine the genetic variation of PCV -2 found that minor 
branches of PCV-2 were associated with geographic origin rather than with differences in 
virulence [55, 103]. The PCV-2 isolates fr<;>m cases of PDNS and abortions were closely 
related to a PMWS-associated PCV -2, further establishing the apparent genetic stability of 
PCV-2 [107]. Four dominant immunoreactive areas are identified by PEPSCAN analysis 
within ORF2 [101]. In 2002,34 Eastern Canadian PCV-2 isolates recovered from pigs with 
various clinical conditions such as PMWS, PRRS, generalized tremors, erysipelas, gastric 
ulcer, nervous signs, arthritis, and no clinical signs, were sequenced, and the obtained 
sequences compared to 36 published sequences. Sequence analysis indicated that all the 
isolates were closely related [91]. Three major regions of amino acid heterogeneity were 
identified among PCV -2 isolates, and two of the regions corresponded to two of the 
immunoreactive areas described before [101]. Comparison of three immunodominant 
regions, however, revealed no link. between the capsid protein variation and the 
pathogenicity of isolates [91]. In addition, PCV-2 from PMWS-affected herds was 
compared to PCV-2 from herds non-affected by PMWS (healthy pigs) [92]. It was found 
that closely related strains in 6 different herds (4 with PMWS and 2 without) sharing at 
least 99.4% of their nucleotide-sequence identity and more than 98.7% of their amino-acid 
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differences can differ significantly in virulence a~ measured by levèls of virus load in serum 
and tissues and severity ofPCV2-associated lesions [127]. 
6.2. The emergence of porcine circovirus 2b genotype (PCV-2b) in swine in Canada 
Restriction fragment length polymorphism (RFLP) preliminary results suggest the 
appearance in 2004 of a new PCV -2 genotype in the province of Ontario (Canada) which 
seems to be related to PCV-2b genotype [21, 47]. Furthermore, it is interesting to obserVe 
that the appearance of a new type of circulating PCV-2 strains (seemed to co!ncide with the 
increases of death rate and PMWS across Canada and particularly in Québec's swine herds 
[42, 47]. Sequence arialysis of the entire viral genome of PCV-2 Canadian strains has 
permitted to establish the appearance of a nèw type of circulating PCV-2 strains in Canada 
[63]. These new strains have been classified in PCV-2b genotype (Fig. 3). Moreover, it is 
now obvious that the PCV -2b genotype straiiIs are more prevalent across Canada than the 
PCV-2a genotype strains [63]. The most variable prote in between PCV-2a and PCV-2b 
~enotypes is the Cap prote in with an aa (amino acids) sequence identity varying between 
88% to 94%. The two other known proteins to be expressed by PCV -2 were less variable 
than Cap protein with a aa sequence identity between the two genotypes varying from 96% 
to 99% for Rep protein and from92% to 98% for ORF3 protein [63]. 
Interestingly, this newly recovered PCV-2 genotype (namedPCV-2b in comparison' 
with the previously circulating genotype named PCV -2a) had already been reported in Asia 
and Europe [46] and has also been recentIy reported in 2007 in the United States [34, 81]. 
Now, an international consensus has been established in regards to the recognition of a least 
two major PCV-2 genotypes circulating worldwide [34, 50, ,63, 67, 120]. Recently, a 
nomenclature has been proposed, one that takes into account the classification of Gagnon et 
al (2007) and identified the two major genotypes (PCV -2a and PCV -2b) as well as a third 
one (PCV-2c) which inc1uded only three 80's isolates that had never been reported later on 
[154]. 
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PATHOGENESIS 
1. Introduction 
The pathogenesis ofPCV-2 infection and the major cell types that supportPCV-2 
replication are poorly understood. The involvement of the immune system in the 
pathogenesis of PMWS seems central (Fig. 4). Two facts support this idea: 1) the existence 
of extensive lymphoid lesions [45] and 2) the association of PMWS with several secondary 
or opportunistic infections [49, 128]. Nevertheless,there are a number of questions that 
remain to be answered: What are the main virus producing ceUs? How does the immune 
response contribute to the development of the syndrome? Why, if most pigs<on a farm are 
infected, only sorne ofthem become ill? 
2. Transmission of PCV-2 
Transmission of PCV -2 is thought to occur through direct contact via oronasal (Fig. 
4), fecal and urinary routes [17,100]. Direct contact with pigs inoculated with PCV-2 42 
days previously resulted in virus transmission to 3. of 3 control cesarean-derived, 
colostrums-deprived (CDCD) pigs [17]. PCV-2 shedding in experimentally infected CDCD 
pigs was identified by polymerase chain reaction (PCR) in oropharyngeal swabs, nasal 
swabs, and feces [157]. In another study, the authors quantified PCV-2 DNA in tonsillar, 
nasal, tracheo-bronchial, urinary and fecal swabs of pigs with .and without PMWS. The 
authors were able to detect PCV -2 DNA in a high percentagè of the samples and concluded 
that PCV-2 iS,most likely excreted t~oughresp'iratory secretions, oral secretions, urine and 
feces of both PMWS':'affected and clinically-healthy pigs, with higher viral loads in the 
PMWS-affected pigs [153]. Vertical transmission has been demonstrated to occur in 
individual sows in the field [89, 118] and experimentally [80]. 
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3. Cellular distribution of PCV -2 and cell-tissue tropisms 
The target cells that support PCV -2 replication are poorly understood. The presence 
of PCV-2 antigen and nucleic acids has been shown in different cell types in vivo (Fig. 4) 
by IHC orJSH [11, 158]. A recent study found that antigen presenting cells in general, and 
not only macrophages stained positive by IHC for PCV-2antigen [35]. In contrast, PCV.:2 
antigen in lymphocytes was only sporadically detected. In thymus, PCV -2 was only 
detected in few histiocytic cells in the medulla suggesting that thymocytes and T cells 
might be more resistant to PCV -2 infection [35]. Irnrnunophenotyping bf the target cells of 
PCV -2 replication in vivo has shown that the susceptible cell population in the pig depends 
on the stage of development of the host at the time of infection. In fetuses, infected cells 
were identified as cardiomyocytes, hepatocytes and macrophages during early gestation and 
mainly macrophages towards the end of gestation [144]. In the majority of unweaned 
piglets, low to moderate PCV-2-replication was demonstrated in macrophages [145]. A 
variety of cell types (Fig~ 4) have also been shown to contain PCV -2 antigens and/or 
nucleic acid such as: enterocytes, renal and alveolar epithelial celIs, vascular endothelial 
celIs, pancreatic acinar' and ductular celIs, lymphocytes, smooth muscle celIs, fibroblasts 
and germinal epithelial cells [45,126,173,174]. 
3.1. PCV -2 and Macrophages 
Viruses that replicate in the monocyte/macrophage lineage such as porcine 
parvovirus (PPV) [9, 122] and porcine reproductive and respiratory virus (PRRSV) [12, 74, 
142], have been shown to increase the replication of PCV -2 in coinfected pigs and increase 
the incidence of PMWS. Despite the presence of PCV -2 in macrophages and dendritic 
celIs, recent in vitro studies suggest that monocytic cells may not represent the primary 
target for PCV -2 replication [65]. Monocytes and macrophages were tested for the ability to 
support PCV -2-replication in vitro. PCV -2 replication in these cell types was not observed; 
however, PCV-2 was not degraded and was stored in the cytoplasm of the cells [65]. 
Similarly, no evidence of in vitro virus replication in dendritic cells was found [169]; 
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however, PCV -2 did persist in dendritic cells without loss of infectivity or the induction of 
cell death. It has been speculated that because of their migratory capacity, dendriticcells 
can provide a potent vehicle for transport of the virus throughout the host without the need 
. ' 
for replication [169]. In vitro studies showed that PCV-2 antigens could only be detected in 
the cytoplasm of PCV -2-inoculated monocyte/macrophage lineage cells, including swine 
alveolar macrophage without virus replication being detected [26, 27]. Nonetheless, two 
swine primary cell lines (alveolar macrophages and peripheral blood mononuclear cells -
PBMC) have been demonstrated to allow PCV -2 infectious viral particles production when 
they were stimulated by bacteriallipopolysaccharide (LPS) or by concanavalin A (ConA) 
[28, 94]. 
3.2. PCV-2 and Porcine Kidney epithelial cellline (PK~15) 
Until now, swine kidney cells (like PK-15 cells) have beeri the only immortalized 
cells shown to be permissive to PCV -2 in vitro, meaning thatthey' allow the production of 
infectious viral particles fol1owing their infection with PCV -2 [106, 142]. On the other 
hand, other primary and immortalized cell lines were shown to be susceptible to PCV -2, 
meaning the cells could be infected and allow viral protein expression ,but without allowing 
infectious viral particles production [26, 28, 65, 110-112, 169]. PK-15 cells support PCV-2 
replication in vitro; and these cells are routinely used for virus isolation and vaccine 
production., PCV -2-induced cytopathic effect is typically not observed, and to determine 
viral replication, immunofluorescent or immunoperoxidase staining has to be performed. 
Since PCV -2 does not encode its own polymerase, the replication of PCV -2, as for other 
circoviruses, depends on the cell polymerase present in the cells nucleus during the S phase 
of the cell cycle [165]. Consequently, glucosamine treatment of the PK-15 cells has shown 
to be effective in increasing PCV -2 replication [165]; 
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3.3. Lymphoid tissues 
Lymphocyte depletion together with histiocytic infiltration are the most 
characteristi~ features of PMWS [8, 39, 45, 52]. The reduction of lymphocytes (Fig. 4) 
might be due to reduced production in the bone marrow, reduced proliferation in secondary 
lymphoid tissues, or due to increased loss of lymphocytes in the bone marrow or peripheral 
blood or secondary lymphoid tissues via necrosis or apoptosis. The severity of lymph node 
depletion can be graded as initial, intermediate, and end stage [146]. Studies on pigs with 
naturally-acquired PMWS revealed that the absence of follicles and depleÙon of 
lymphocytes was associa:ted with a reduction in the number of interfollicular dendritic cells 
and interdigitating ceUs as well as a reduction or absence Of B cells and CD4+ T 
lymphocytes [146]. By IHC characterization of PCV-2-associated lesions in naturally-
PMWS-affected pigs, Chianini et al. (2003) [35] found increased numbers of macrophages. 
and partial loss and redistribution of antigen presenting ceUs throughout lymphoid tissues 
when compared to healthy control pigs. Decrease' of proliferation of both, . lymphoid and 
medulla-like tissues in the initial stage of PMWS, but not in the' intermediate or final stage, 
has been reported [35]. 
Depletion in B-cell associated areas of lymph nodes has been linked to apoptosis 
induced by the' virus [156]. In contrast, when inguinallymph nodes of pigs with naturally 
acquired PMWS were investigated, it was found that decreased cellproliferation (and not 
increased apoptosis) seemed to be the most important variable leading to Iymphoid 
depletion in PMWS[102]. The tissues from experimentally PCV-2 infected pigs were 
investigated by TUNEL staining and a positive signal was found only within the cytoplasm 
of virus-positive phagocytic mononuclear cells. It was concluded that apoptosis is not the 
primary mechanism oflymphoid depletion and hepatocyte loss in PMWS [87]. 
3.4. Blood 
The hemogram ofpigs with PMWS (Fig. 4) shows' significant alterations [44, 148]. 
In wasted pigs, the number of lymphocytes is significantly decreased (especially of CD8+ 
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and B cell subsets) and monocytes and neutrophils are clearly increased, with an inversion 
of the ratio lymphocyte/neutrophil [44, 148]. A typical profile may be 60-70% neutrophils 
and 30-40% lymphocytes; while their theoretical numbers should be reverse [148, 149]. 
However, the total number of leukocytes is not altered. Pigs with PMWS usually have 
normocytic hypochromic anemia with a slight increase in the total number of red blood 
cells [44, 148]. 
4. Cytokine profiles in PMWS diseased pigs 
Pigs with PMWS have altered cytokines mRNA expression patterns (Fig .4.) in 
different lymphoid tissues [44]. These alterations consist of an over expression of IL-lO 
mRNA in thymus and INF-y mRNA in tonsil. The IL-lO mRNA over expression has been 
associated to thymic depletion and atrophy in the diseased animals [44]. A decrease in the 
mRNA expression was se en for IL-2 in the spleen, IL-4 in tonsils and lymph nodes, IL-
12p40 in both spleen and inguinal lymph nodes and IFN-y and IL-lOin inguinal lymph 
nodes [44]. With regard to pro-inflammatory cytokines, it has been reported that IL-8 
mRNA levels are high in tissues with slight or moderate lesions and with small amount of 
virus, while it is low in tissues with severe lesions [44]. 
On the other hand, in vitro PCV -2 alone modifies the cytokine responses of PBMC 
(Fig. 4) from healthy pigs when stimulated with mitogens such as phytohemaglutinin 
(PHA) or superantigens [43]. 
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Figure 4. Pathogenesis of PMWS caused by PCV -2. Proposed outline of the pathogenesis 
including immunologie aspects of PMWS in clinical and sub-clinical PCV -2 infections of 
piglets. Taken from Darwich et al. (2004). 
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5. Risk factors involved in PMWS development 
, ' 
Evidence from the field supports the thought that PMWS is multifactorial in 
causality and that not aH pigs that are infected with PCV -2 will develop clinical P.MWS 
[128]. Factors that are currently thought to influence the outcome of PCV-2 infection can 
be broken down (Fig. 5) into 4 main areas of focus: virus, host, co-infections and immune 
modulation. Experimental work has confirmed that at least these 4 components are the key 
building blocks, identified to date, in the PMWS models [128]. 
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Figure 5. Co-factors involved in the disease development. A current model of the 
understanding of the progression of PCV -2 infection. Taken from from Opriessnig et al. 
(2007) , 
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Genetic analyses and sequence comparison of PCV -2 isohites to date have failed to 
fully explain differences in clinical manifestations. Then, one of the main objectives of the 
swine industry and health scientists is to establish if there is a virulence variation between 
both PCV-2 genotypes (PCV-2a and PCV-2b). 
Host susceptibility and its role in PMWS development are po orly understood. Pigs 
of aIl breeds seem to be susceptible to PCV -2 infection and clinical PMWS has been 
observed in a wide variety of purebred and crossbred pigs. Host susceptibility and its effect 
on the outcome of PCV -2 infection were recently investigated in a controlled pilot project 
[124]. Three breeds were compared in this study: Duroc, Landrace and Large White. The 
incidence of systemic PMWS based on gross and microscopic lesions was 0% (0/23) in 
Durocs, 15.8% (3/19) in Landrace, and 0% (0/21) in Large White [124]. The purebred 
Landrace pigs used in this experiment were clearly more susceptible to PMWS diseases as 
measured by the severity of clinical signs and microscopic lesions associated with PCV-2 
[124]. A recent in vitro study investigating the replication patterns of PCV -2 in pulmonary· 
alveolai macrophages found clear differences between macrophages derived from different 
, conventional crossbred pigs suggestive of differences in susceptibility to PMWS [109]. 
The primary etiological agent responsible for PMWS has been identified as a PCV-
2 [70]. The course of PCV -2 infection that will lead to the occurrence of the disease .has 
been associated with the presence of other pathogens such as Mycoplasma 
hyopneumoniae, Porcine parvovirus (PPV), Porcine reproductive and respiratory 
syndrome virus (PRRSV), and Swine influenza virus (SIV) [128]. Experimental coinfection 
ofpigs with PCV-2 and other virus es such a PPV [9, 14,81,85, 122], PRRSV [12, 74, 142] 
or bacteria such as Mycoplasma hyopneumoniae [123] has been shown to enhance the 
amount of PCV -2 viralload and PCV -2-associated lesions, and to increase the incidence of 
PMWS. 
Studies have demonstrated that immunostimulation may trigger progression of 
PCV -2 infection to disease and characteristic lesions of PMWS. The PMWS was 
reproduced in gnotobiotic pigs stimulated with keyhole limpet hemocyanin in incomplete 
Freund adjuvant (KLHlICFA) and inoculated with PCV-2 [4, 86, 88, 121]. A recent study 
has determined that the timing of vaccination with a commercially available M 
hyopneumon~ae vaccine had an effect on PCV-2 replication and PCV-2-associated lesion 
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severity. It also confirmed differences in PCV-2-associated lesions among the treatment 
groups and conc1uded that no or minimal PCV -2-associated lesions were observed when 
pigs were vaccinated 2 to 4 weeks prior to expected PCV-2 exposure [125]. A study was 
conducted to determine if the adjuvants (as opposed to the antigen) in commercial swine 
vaccines increase replication of PCV -2 and incidence of PCV -2-associated disease. It also 
considered the possible difference between adjuvants in this regard [78]. Under the 
conditions of the study, it was found that by the later stages of infection (35 days 
postinoculation), the pigs vaccinated with the oil-in-water adjuvants had an increased 
length of PCV -2 viremia, increased amount of PCV -2 in serum and tissue and increased 
severity of lymphoid depletion comparedto pigs vaccinated with the aqueous and 
aluminum hydroxide products [78]. 
PMWS is most often observed in pigs between 5 and 12 weeks of age with most 
cases occurring bètween 6 and 10 weeks of age [128]. Reports of PMWS in adult pigs are 
rare. PCV-2 associated lesions are typically observed from 14 to 35 days post PCV-2 
inoculation in experimental studies [45, 128]. 
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DIAGNOSIS 
Generally, diagnosis of viral diseases in swine is based on detection of the virus by 
culture, PCR, IHC or ISH, and/or detection of virus antibodies by serology. However, 
diagnosis of PMWS is different from this general diagnostic approach because PCV -2 can 
be detected in normal healthy pigs [11, 19, 82, 83]. The detection of PCV-2 alone does not 
necessarily confirm a diagnosis of PMWS. Therefore, the diagnosis of PMWS must meet 
three criteria: (i) the presence of compatible clinical signs, (ii) the presence of characterisÙc 
microscopic lesions, and (iii) the presence ofPCV-2 within these lesions ·[158]. These three 
criteria separately are not diagnostic of PMWS. Currently, IHC or ISH are considered the 
gold standard for detecting PCV -2 within characteristic microscopic lesions as part of the 
diagnosis ofPMWS [158]. 
Based on RFLP and gene sequence comparison "results, PCV -2b was suggested to 
be associated with the mortality rate increase observed in several Canadian swine herds 
[23]. Consequently, even if no experiment confirms yet if the PCV-2b strains found in 
Canada are morè virulent than previously circulating PCV -2a strains, it became important 
to develop a low cost (compared to entire" viral genome sequencing) diagnostic test that 
could rapidly and efficiently differentiate both genotypes. 
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INTERVENTION STRATEGIES 
1. Good management practices 
Prior to the availability of PCV-2 vaccines in 2006 in North America, successful 
treatment and control of PMWS had primarily focused on ensuring good production 
practices that minimize stress, eliminate co-infections or minimize their effect, and 
eliminate potential triggering factors that induce immune stimulation and trigger _ 
progression of PCV-2 infection to PMWS. A 20-point plan to control PCVAD on severely 
affected farms was proposed [98]. The main points of this plan have been summarized as 
the 4 golden rules (www.thepigsite.com. accessed April 10, 2007) and inc1ude 1) limiting 
pig-to-pig contact, 2) reduction of stress, 3) good hygiene and 4) good nutrition. 
Use of disinfectants in buildings and transport vehic1es that have been demonstrated 
to be efficacious against PCV-2 transmission [143] is r~commended. For instance, with 
sodium hydroxide and Virkon S (Antec International, Sudbury, Suffolk), a reduction of in 
vitro virus titers was observed. 
2. PCV -2 vaccines 
Evidence to date indicates that the commercial vaccines (Table 1) are a remarkably 
effective tool to reduce losses in herds and production systems experiencing PMWS in 
growing pigs. The inactivated, oil-adjuvanted PCV -2-vaccine (CIRCOVAC, Merial Corn, 
Lyon, France) licensed for use in breeding-age animaIs was the first vaccine on the market 
and has been used most extensively in Europe (Table 1). CIRCOV AC has been shown to 
be beneficial -in reducing PCV -2 circulation and shedding in the first weeks of life and 
improving pig health under experimental conditions [29]. During field efficacy studies in 
Germany and France, the use of CIRCOV AC resulted in a rise in PCV -2 antibody levels in 
the breeder herds and a concurrent decrease in PMWS rates in the growing pigs [29]. When 
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used in Canada in 2006, field trial~ demonstrated that CIRCOV AC significantly (P<0.05) 
decreased mortality (6.4-8.3% prior to vaccination) [132]. 
A conditionally licensed product (Circurnventtm PCV - Intervet Inc, USA) fo~ use in 
growing pigs became available to the North American market in April 2006 (Table 1). 
Investigations induding pigs, on 21 Canadian farms showed that the mortality rate In 
vaccinated pigs was lowered by 77.5% when compared with nonvaccinated pigs [68]. 
SuvaxynH PCV-2 One Dose TM (Fort Dodge Animal Health, Fort Dodge, lA) is 
the first US Department of Agriculture-approved and fully licensed commercial PCV-2 
vaccine in the United States (Table 1). This is the killed version of the live chimeric PCV-
1-2 virus [57, 59]. Preliminary results froin severallarge fields studies in the United States 
demonstrated significantly decreased mortality (P<O.OO1) with the use of the killed 
chimeric vaccine, accompanied by reduced treatment costs compared to those encountered 
for nonvaccinated pigs [40]. 
Preliminary results from field trials using the baculovirus expressed PCV -2 vaccine 
Ingelvac CIRCOFLEX TM (Boehringer Ingelheim Vetmedica Inc., St. Joseph, MO) (Table 
1) also demonstrated significant reduction in mortality (P<0.003) in vaccinated pigs 
compared to nonvaccinated pigs on four Canadian finishing sites [48]. 
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Table J. Commercial PCV -2 vaccines available in North America. 
Vaccine 
Ingelvac® Suvaxyn® CIRCUMVENT 1m CIRCOVAC® 
CIRCOFLEX™n PCV-2 One PCV 
Dose™m 
Antigen PCV-20RF2 Inactivated PCV -2 expressed Inactivated PCV-2 
protein expressed PCV-1-2 in inactivated 
in inactivated chimera baculovirus 
baculovirus 
Dose 1 mL 2 mL lM; 2 mL lM; 2 2 mL lM; 
intramusculary single dose injections 3 wks Primary 
(lM); single dose apart vaccination: 2 
injections 3-4 wks 
apart, at least 2 wks 
before mating 
Revaccination: 1 
injection at each 
gestation, at least 2-
4 wks before 
farrowing 
Licensed Healthy p igs 3 Healthy pigs Healthy pigs 3 wks Healthy female 
for wks and older 4 wks and and older breeding-age pigs 
older 
Available United States United States United States; Canada; Europe 
Canada 
Adapted from Opriessnig et al. (2007). 
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EXPERIMENTAL INFECTION MODEL OF PMWS 
Experimental PCV2-infection models indicate that PCV -2 is an opportunist, 
depending on immunostimulation [13, 15,86] or coinfecting agents like PPV [9, 14,53, 76, 
81, 84, 85, 122, 130], PRRSV [12, 74, 142], or M hyopneumoniae [123] for PCV-2 
infection to progress to clinical PMWS. While most research groups have not been able to 
reproduce clinical disease in pigs inoculated singularly with PCV -2, sorne groups have 
succeeded. In early experimental models, piglets inoculated with PCV -2 alone only 
developed a very mild clinical disease with slight histologicallesions characteristic to those 
ofPMWS [9, 16, 100]. 
A cofactor was needed for immune stimulation· to reproduce the disease. This 
hypothesis arose from experiments using days-old gnotobiotic piglets inoculated with PCV-
2 and keyhole limpet haemocyanin in incomplete Freund's adjuvant (KLHlICFA) [86]. In 
that experiment, the piglets developed PMWS in higher proportion and with higher severity 
than the unstimulated animaIs, which developed a subclinical PCV -2 infection. This 
hypothesis was further explored under natural conditions. Others authors [88] showed that 
conventional on-farm pigs inoculated with a parapoxvirus immunomodulator combined 
with a vaccine against M hyopneumoniae developed more severe clinical signs than pigs to 
which none of the above was administered and were only naturally exposed to the virus. 
Different type of animaIs models were used in experimental infection, such as 
gnotobiotic pigs [85], colostrums deprived cesarian derived (CDCD) pigs [17, 74, 134], 
colostrums deprived (CD) pigs [5,9, 12] andconventional pigs [1, 16,90]. 
Fenaux et al. (2002) investigated the infectivity of an US PCV-2 molecular 
infectious DNA clone. The infectious clone was directly inoculated into the liver or 
inguinal lymph nodes and mild PCV -2-associated lesions were. observed in 4-weeks-old 
conventional pigs confirming the role ofPCV-2 in PMWS [56]. 
· III. MATERIAL, METHODS & RESULTS 
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Abstract 
The pathogenesis of Porcine circovirus type 2 (PCV -2) infection and the major cell 
types that support PCV -2 replication in vivo are still not fully understood. Until now, the 
porcine kidney cellline (PK-15 and its derivative) was known to be the only immortalized 
cell line· permissive to PCV -2 replication. The goal of this study was to establish if 
epithelial cells of the respiratory tract of swine could support PCV -2 replication in vitro. 
The newbom piglet tracheal (NPTr) epithelial cells were discovered to be permissive to 
PCV -2 infection f~llowing l) the detection of the nucleocapsid protein in PCV -2 infected 
cells and 2) infectious viral particles production. In addition, no difference was observed 
between the kinetics of PCV-2 infectious viral particles production in NPTr and PK-15 
infected cells (P>O.05). These results suggest that the epithelial cells of the respiratory tract 
of swine can be the primary cell target for PCV -2 replication and could subsequently 
provide a way of entry in swine. In conclusion, the NPTr cellline could be used as a new in 
vitro mode! for studying PCV -2 pathogenesis. 
Key words: NPTr cells, PK-15 cells, PCV-2 repli cation 
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Introduction 
. Postweaning multisystemic wasting syndrome (PMWS) is a swme disease first 
recognized in Canada in 1991 [15,28]. Afterwards, the syndrom~ was reportèd worldWide 
[5]. The disease usually affects 5 to 12 weeks old piglets and is characterized in part by 
weight loss, dyspnea, jaundice, and enlarged lymph nodes, as weIl as by degeneration and 
necrosis of hepatocytes, multifocal lymphohistiocytic pneumonia, lymphocyti~ depletion, 
and multinucleated giant cell formation [28, 52]. Depletion of lymphocytes in the lymphoid 
follicles and their replacement by macrophages are the hallmark lesions observed in this 
syndrome [1, 36]. The etiological agent responsible for PMWS has been identified as a 
circovirus named porcine circovirus-2 (PCV-2) [36]. Today, the clinical expression of 
PCV -2 infection in swine is acknowledged to be more complex than initially established 
because it can play a pivotaI role in several syndromes, such as porcine respiratory disease 
complex (PRDC), porcine dermatitis and nephropathy syndrome (PDNS), reproductive 
failure, granulomatous enteritis, necrotizing lymphadenitis, exudative epidermitis and 
congenital tremor [6, 29]. Consequently, the term "Porcine circovirus-associated disease 
(PCV AD)" is now accepted to describe the syndromes in which PCV -2 plays a role. 
Porcine· circovirus (PCV) are smaIl, icosahedral, non-enveloped virus es with a 
circular single-stranded (ss) DNA genome of 1.7 kb [36, 54]. PCV are among the smallest 
known mammalian viruses with a diameter of around 17 inn [53]. It is composed of coat 
prote in subunits assembled in 12 pentameric units [16]. PCV-2 genome contains three main 
open reading frames (ORFs), which are the ORFI (314 aa) encoding the replicase protein 
(Rep); the ORF2 (233 aa) encoding the" immunogenic capsid prote in (Cap); and the newly 
characterized prote in encoded by ORF3 (105 aa) which appears to contribute to virus-
induced apoptosis ofhost infected cells [11, 12,34,35,40]. It is noteworthy that there are 
at least two PCV -2 genotypes that are presently circulating worldwide but there is no 
. international consensus about the nomenclature that should be used to identify them [13, 
24,27,41]. 
The pathogenesis of PCV-2 infection and the major ceIl types that support PCV~2 
replication are poorly understood. The presence of a PCV -2 antigen and nucleic acids has 
been shown in different cell types in vivo by immunohistochemistry (IHC) or in situ 
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hybridization (ISH). It has been suggested that PCV-2 initially replicates in the tons il [3]. 
Large amounts of PCV -2 antigen or nucleic acids are found in the cytoplasm of 
macrophages and dendritic cells replacing lymphocytes in the depleted follicles in 
lymphoid tissues [2, 52]. In thymus, PCV -2 was only detected in few histiocytic cells in the 
medulla suggesting that thymocytes and T cells might be resistant to PCV-2 infection [14]. 
Immunophenotyping of the target cell of PCV -2.:.replication in vivo has shown that the 
susceptible cell population in the pig depends on the stage of development of the host at the 
time of infection. In fetuses, infected cells were identified as cardiomyocytes, hepatocytes 
and macrophages during early gestation and mainly macrophages towards the end of 
gestation [48]. In the majority ofunweaned piglets, low to moderate PCV-2-replication was 
demonstrated in macrophages [49]. A variety of cell types has also been shown to contain 
PCV -2 antigens and/or nucleic acid such as: enterocytes, renal and alveolar epithelial cells, 
vascular endothelial cells, pancreatic acinar and ductular cells, lymphocytes, smooth 
muscle cells, fibroblasts and germinal epithelial cells [17,43, 56, 57]. Despite the presence 
of PCV -2 in macrophages and dendritic cells, in vitro studies suggest that monocytic cells 
may not represent the primary target for PCV-2 replication [26]. Monocytes and 
macrophages were tested for the ability to support PCV -2 replication in vitro. PCV-2 
replication in these cell types was not observed; however, PCV -2 was not" degraded in the 
cytoplasm of the cells [26]. Similarly, no eviderice of virus replication in dendritic cells in 
vitro was found [55]. However, PCV-2 did persist in dendritic cells without loss of 
infectivity [55]. Ithas beenspeculated that because of their migratory capacity, dendritic 
cells can provide a vehicle for transport of the virus throughout the host [55]. Porcine 
monocytic ceU line 3D4/31 is susceptible to PCV -2 inJection but not permissive to virus 
. replication [38, 39]. Moreover, in vitro studies showed that PCV -2 antigens could only be 
detected in the cytoplasm of PCV -2-inoculated monocyte/macrophage lineage cells, 
including swine alveolar macrophages without virus replication being detected [7, 8]. 
Nonetheless, swine alveolar macrophages have been demonstrated to allow PCV-2 
replication when they are stimulated by bacterial lipopolysaccharide (LPS), but this result 
has to be confirmed because of the existence of contradictory reports [9,22]. 
Therefore, what are the main virus producing cells? Swine epithelial cells are 
known to be PCV -2 infected in pigs with naturally occurring PMWS [31, 46]. In vitro, 
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sorne porcine epithelial cells such as the ST cell line, have been shown to be susceptible to 
PCV-2 infection but not permissive to virus replicatiop [39]. The PK-15 and SK porcine 
kidney epithelial cell lines are the only immortalized cell lines known -toallow PCV-2 
replication [36, 47]. Nonetheless, it is a good assumption to believe that kidney cells are not 
the first infected cells that favor propagation of the virus in the organism. The oro-nasal 
route is considered the most likely and frequent route of PCV -2 transmission, and 
experimental infection studies, which have mainly used the intranasal route of inoculation 
support that idea [l, 4, 20, 32, 33, 47]. Consequently, theaim ofthis study was to estabÎish 
if epithelial cells of the respiratory tract of swine could support PCV -2 replication in vitro. 
In this study, the PCV -2 permissivity of a few swine cell lines was investigated. The 
present study demonstrates that the newborn piglets tracheal (NPTr) immortalized epithelial 
cellline [23] is permissive to PCV-2 replication. 
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Materials and Methods 
Virus and ceUs. The FMV -06-1717 PCV -2 reference strain, used in the présent 
study has been previously characterized as a member of the PCV-2b genotype [25]. This 
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virus was propagated into PK-15A cells, a subclone of PCV-1 noninfected PK-15 cells 
[45], and the virus was purified and concentrated following ultracentrifugation on a 30% 
sucrose cushion using the SW28 Beckman Coulter rotor (Beckman Coulter Canada Inc., 
Mississauga, Ontario, Canada) at 83 000 relative centrifugaI force (rct) during a 5 br 
period. The virus pellet was resuspended in 2 mL of a phosphate buffer saline (PBS) 
containing 2% fetal bovine serum, and aliquots of the virus stocks were then conserved at -
70°C for future use. The infectious dose of the virus stock was determined from a 96-w~ll 
microplate of PK-15A-infected cells following immunofluorescence assay (IFA) [45] by 
the Karber method (Payment P, Trudel M: 1989, Manuel de techniques virologiques, 
Presses de l'Université du Québec, Québec). For the calculation of the virus titer, a well 
was considered to be positive for PCV -2 if specific fluorescence was detected in cells 
regardless of the amount of immunofluorescept positive cells. The virus titer was expressed 
in tissue culture infectious dose 50 per mL (TCIDso/mL). The titer of the PCV-2 stock used 
was determined to be 1 x 107 TCIDso/mL. The PK-15A cells were maintained at 37°C in 
5% CO2 atmosphere in Minimum Essential Medium (MEM) with Earle's salts (Invitrogen 
Corporation, GibcoBRL, Burlington, ON, Canada), supplemented with 10% fetal bovine 
serum (FBS) (Wisent Inc, St-Bruno, QC, Canada), 300 U/ml of penicillin , 300 mg/ml of 
streptomycin, 0.1 mM non-essential amino acids, 1 mM sodium pyruvate and 10,mM 
HEPES.' The NPTr cells (kindly provided by Dr. M. Ferrari) [23] were grown at 37°C in 
5% CO2 in MEM with Earle's salts (Invitrogen .corporation, Canada), supplemented with 
10% fetal bovine serum (FBS) (Wisent Inc, St-Bruno, QC, Canada), 300 U/ml ofpenicillin, 
300 mg/ml of streptomycin, 1mM sodium pyruvate (Invitrogen Corporation, Canada). 
Immunofluorescence assay. To titer the PCV-2 virus stock and to determine the 
PCV -2 permissivity of celllines, an IF A was performed as previously described with sorne 
modifications [45]. Briefty, an amount of 3 x 104 NPTr cells were seeded per well in an 
eight-well LabTek chamber slides (Nalge Nunc International, Rochester, NY, USA) and 
38 
cells were immediately infected while in suspension with FMV -06-1717 PCV -2 reference 
strain at a multiplicity of infection (MOI) of l. PK-15A cell suspensions were infected 
simultaneously using the same conditions as positive control. Mock-infected cells were 
included as negative controls. At 3 days post infection (Pi), cells were washed three times 
with sterile PBS solution and fixed with a solution containing 4% paraformaldehyde (PF A) 
in PBS for 20 min. Then, the cells were washed three times with PBS and they were 
permeabilized with a solution containing 0.1% triton X·100 in PBS for 10 min. Finally, 
cells were rinsed three times with a solution containing 0.02% Tween-20 in PBS (PBS-T). 
All the PF A fixation steps were done at room temperature. Afterwards, cells were 
incubated in a solution containing 1 % bovine serum in PBS-T for 20 min to block 
unspecific binding of the antibodies. After this step, cells were incubated with a 1 :200 
dilution of the polyclonal PCV -2 porcine serum [45] at 37°C for 90 ~in. Then, cells were. 
washed three times with a solution containing 1 % bovine serum in PBS-T and incubated 
with a rabbit anti-pig FITC conjugated antibody (MP Biomedicals, Solon, OH, USA) 
diluted 1 :75 at 37° C for 60 min. Thereafter, the ceÙs were washed three times with a 
solution containing 1 % bovine serum in PBS-T followed by three washes with PBS only. 
Then, cells were visualized using a DMI 4000B reverse fluorescence microscope. 
Photographs of t~e cells were taking with a DFC 490 digital camera and the images were 
analyzed using the Leica Application Suite Software, version 2.4.0 (Leica Microsystems). 
PCV-2 infectious viral particles production. Initially, two flasks containing 5 x 
105 PK-15Aand NPTr cells each were infected in suspension with FMV-06-l7l7 PCV-2 
reference strain at 0.005 MOI. At 96 hrs pi, one infected flask of each cell type was 
harvested following three cycles of freeze and thawed at - 70°C. After centrifugation at 
2000 rpm at 4°C for 10 min, the supematant containing PCV-2 free virus particles was 
collected and theamount of virus was determined by Karber method in PK-15A cells (see 
above). The remaining infected cells of the other flask were trypsinised, divided and seeded 
into two new flasks and then cells were reinfected with a 1:6 dilution of the previously 
collected PCV -2 virus, which will be accounted for a subsequent virus infection cycle. The 
same protocol was carried out 4 times for subsequent passages. Following each passage 
mock-infected cells were included as controls. 
39 
PCV .. 2 replication kinetic in PK-15A and NPTr cells. 1 x 105 PK-15A and NPTr 
cells were infected in suspension with FMV-06-1717 PCV-2 reference strain at 1 MOI. At 
4 hrs pi, the cells were washed five times with sterile PBSand fresh culture medium was 
added. At each time post infection (0, 4, 6, 12, 18, 24, 48, 72, 96 and 120 hrs pi), the 
infected cell cultures were collected and centrifuged at 2000 rpm at 4°C for 10 min. Then, 
cell pellets and supematants were stored at -70°C until virus titration was realized in PK-
15A cells (see above). Before titration, all pellet samples were frozen and thawed three 
times to free infectious viral particles, and cell debris were discarded after centrifugation at 
2000 rpm at 4°C for 10 min. Mock-infected controls were included in each experiment. All 
experiments were performed two times in triplicate. 
Statistical analyses. The statistical analyses were realized using the GraphPad· 
Prism version 4 software. The paired t test and the regular two-way ANOV A combined 
with the Bonferroni post-tests models were used to determine if there is statistical 
significant difference between PK-15A and NPTr celllines in regards to their efficiency to 
allow the replication and production of PCV -2 infectious viral particles. 
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Results 
Identification of the NPTr PCV -2 permissive cell line by immunofluorescence 
assay. In the perspective to find out new cell lines permissive to PCV -2 infection, sorne 
porcine celllines were infected with 1 MOI ofPCV-2 (data not shown). Interestingly, only 
one cell type, the NPTr cells, was found to express PCV -2 antigens when PCV -2 infected 
(Fig. 1). The NPTr infected cells were shown to contain a high level of PCV -2 Cap antigen 
since they reacted very strongly to specific porcine polyclonal anti PCV -2 antibody (Fig. 
Ic). Both intracytoplasmic and intranuclear positive signaIs were found in PCV-2 NPTr 
infected cells with a higher amount of antigen detected in the nucleus as illustrated in the 
inset of Fig. 1 c. The ratio of the NPTr infected cells expressing the PCV -2 antigens was 
very similar to the control PK-15A infected cells (data not shown). As expected, the NPTr 
mock-infected cells were negative for the expression of PCV -2 antigens (Fig. 1 d). 
Interestingly, following visualization by phase contrast microscopy of PCV-2 NPTr 
infected cells, no major cytopathic effect (CPE) was observed compared to mock-infected 
cells (Fig. 1 a and 1 b). Nonetheless, at 72 hrs pi, differences in the cell morphology could be 
seen in several NPTr infected cells and showed a marked increases in cell size and 
particularly in their nucleus size compared to mock-infected cells (Fig. la and lb insets). 
Furthermore, the NPTr cells were not only permissive to PCV-2b genotype virus (Fig. 1), 
but were also permissive to PCV-2a genotype virus [24] (data not shown). 
PCV-2 infectious viral particles production at different cell passages. Following 
the confirmation that the NPTr cell~ were able to express PCV-2 antigen, the efficacy of the 
NPTr cells to allow a complete virus replication cycle and produce PCV -2 infectious 
particles had to be determined. The amount of PCV-2 virus production in PK-15A and 
NPTr infected cells was evaluated during five consecutive passages (Fig. 2). To make sure 
that the NPTr infected cells were able to produce infectious viral particles, a very low 
amount of virus was used in the initialinoculum in hope that the virus yields production 
will increase during subsequent cell passages. Consequently, the amount of PCV-2 in the 
initial inoculum used to infect NPTr cells at the first passage of the assay following dilution 
of the virus stock was 4.17 x 102 TCID50/mL (Fig. 2). Interestingly, at the first passage, 
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1.78 X 103 TCIDso/mL infectious viruses were found in both PK-15A and NPTr infected cell 
lysates suggesting that infectious viral partic1es were produced. At subsequent cell 
passages, the virus yields in both cell lines increased until the 5th passage, at which the 
amount ofPCV-2 virus recovered from ceIllysates was 3.16 x lOs TCIDso/mL for bothcell 
lines. Statistical analysis revealed that there was no significant difference between PCV-2 
infectious partic1es yields from NPTr and PK-15A infected cells (P=0.2832) even if a 
smaller amount of virus was recovered from NPTr infected cells at passage 3 and 4 (Fig. 2). 
PCV-2 replication kinetic in PK-15A and NPTr cells. To confirm the previous 
results in regards to the virus yields obtained from NPTr and PK-15A infected cells at 
different cell passages, the PCV -2 replication kinetic in both cell lines was compared. At 
different times pi, the PCV -2 replication kinetic in both cell lines and the amount of virus 
yields was observed in culture medium (or supernatant) and in cell (or cell pellets)~ Virus 
titers obtained in the supernatants and cells at different times pi are illustrated in Fig. 3. 
Interestingly, the PCV-2 infectious partic1es production was c1eariy demonstrated in NPTr 
cells since the amount of virus recovered at 120 hrs pi was 4465 and 794 times higher 
compared to 4 hrs pi in cell pellets and the culture medium, respectively. Furthermore, a 
significant increase in PCV -2 infectious partic1es production started to appear in both cell 
lines at 48 hrs pi since the amount of virus recovered was 45 to 316 times highercompared· 
to 4 hrs pi. No statistical significant difference was observed in the overall PCV-2 
replication kinetic in PK -15A and NPTr cells (P>0.05) since the virus yields in the culture 
medium and cell fractions were very similar with one exception at 72 hrs pi where a 
significant difference between the virus yields in PK-15A and NPTr cell pellets was 
observed (P<O.OOl) .. Interestingly, at 72 hrs pi and until the end of the experiment, the 
amount of PCV -2 recovered in each cell line from the cell fractions was lOto 20 times 
higher compared to the virus recovered from the supernatant (P<O.OOl) (Fig. 3), suggesting 
that PCV -2 was weakly released from infected cells. 
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Discussion 
Since PCV -2 transmission is considered to occur most likely via· the oro-nasal route 
and because epithelial cells of the respiratory tract were found to be positive by ISH and 
IHC [17], it was logical to evaluate if celllines from the respiratory tract could permit the 
replication of the virus even if until now, swine kidney cells have been the only 
immortalized cells shown to be permissive to PCV -2 replication in vitro [36, 47]. 
Consequently, different celllines were evaluated for their capacity to allow the replication 
of PCV -2. Surprisingly, the newly established NPTr cell line [23] was found to be 
permissive to PCV -2 replication (Fig. 1, 2, and 3). Moreover, the NPTr cells were 
statistically identical to PK-15 cells in regards to their efficacy to pro duce infectious viral 
partic1es (Fig. 3) suggesting that NPTr cells could replace the PK-15 cells in terms of 
vaccine production. Unfortunately, Ferrari et al (2003) [23] have suggested that those cells 
could not be used for vaccine production according to the U.S. Food and' Drug 
Administration (FDA) guidelines since they contain porc~ne endogenous retro virus (PERV) 
and they possess transforming activity. Interestingly, the NPTr cells were already known to 
permit the replication of several swine viruses such as pseudorabies virus, pig parvovirus, 
hog cholera virus, transmissible gastroenteritis virus of swine, encephalomyocarditis virus, 
swine vesicular disease virus and enteroviruses [23]. Furthermore, the NPTr cells are 
permissive to a variety of sub-types of influenza virus from hwnan, swine, avian. and horse 
origins. Consequently, from now on, PCV-2 can be added to this exhaustive list ofviruses 
that can replicate in NPTr cells. Noteworthy, the NPTr cells can be a useful tool for virus 
isolation in a virology diagnostic laboratory since they permit the replication of a large 
variety of swine viruses [23]. 
In addition to the experiment illustrated in Fig. 1, PCV -2 NPTr infected cells were 
fixed and stained at different times pi (24, 48, 72, 96 and 120 hrs pi) (data not shown). It 
was noticed that the expression of the PCV-2 antigens began at 24 hrs pi. Between 48 hrs to 
96 hrs pi, an increased nwnber of PCV -2 positive cells was observed. At 96 hrs pi and until 
the end of the experiment, the observed nwnber of PCV -2 positive cells was at a constant 
maximum level, a phenomenon that appeared 24 hrs after what has been previously 
reported by others [10, 37, 58]. In addition, at 96 hrs pi and until the end of the experiment, 
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an increased number of detached cells was observed. It is possible that the cel1~ may have 
died following PCV-2 infection as previously described with PK-15 cells [37, 58], but 
further experiments will have to be conducted to determine if detached cells are dying cells. 
In an earlier study of Yu et al. (2007) [56], following an evaluation of microscopic 
lesions, it was suggested that PCV -2 replication begins in the lymph nodes at the nearest 
site of virus entry and infection. Moreover, their results suggest that the lymph nodes near 
the infection site may also play an important role in PCV -2 persistence in the infected host. 
On the other hand, the present study suggests that epithelial cells of the respiratory tract of 
swine may potentially be more involved in the pathogenesis of the viral infection such as 
virus entry and proliferation than previously thought since it was c1early demonstrated that 
PCV -2 could replicate in an epithelial cell line of the respiratory tract of swine like the 
NPTr cells (Fig. 3). Moreover, it is consistent with the fact that one of the most frequent 
c1inical signs observed in PMWS cases are related to respiratory problems [6, 15, 19, 30, . 
44, 50, 51]. Consequently, these results suggest that, in vivo, the epithelial cells of the 
respiratory tract of swine could be the primary cell target for PCV -2 replication but further 
experiments will have to be conducted to support this affirmation. 
As reported by Gagnon et al. (2008) [25], logistic regression analyses revealed that 
PCV -2 increased the odds ratio of isolating two major swine pathogens of the respiratory 
tract; Actinobacillus pleuropneumoniae and Streptococcus suis serotypes 1/2, 1,2,3,4, and 
7, which are serotypes commonly associated with c1inical diseases. Others have also 
reported that the odds ratio to find S. suis increased significantly in PCV -2 positive animaIs 
[18]. In addition, PCV -2 has been reported to support and exacerbate the establishment of 
secondary bacterial infections such as Mycoplasma hyopneumoniae [18, 21, 42]. The fact 
that epithelial cells of the respiratory tract of swine are permissive to PCV -2 replicati6n 
may favor the establishment of secondary bacterial infections which in return could be the 
cofactors necessary for thedevelopment of PMWS. Work is now in progress to determine 
ifPCV-2 has an impact in/regards to the susceptibility of NPTr cells to secondary bactèrial 
infections. But most importantly, the present finding of the NPTr cells being permissive to 
PCV -2 replication can lead to the establishment of a new interesting in vitro model for 
studying the pathogenesis ofPCV-2. 
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Figure 1. Detection of NPTr PCV -2 infected cells by immunofluorescence assay. NPTr 
cells were fixed at 72 hrs pi with a 4% PF A solution followed by incubation with porcine 
polyclonal anti-PCV -2 serum (Racine et al., 2004) and stained with anti-porcine FITC-
conjugated secondary antibody . Panel A and C: NPTr PCV-2 infected cells with 1 MOI. 
Panel Band D: mock-infected NPTr cells. Upper panels (A and B): NPTr cells visualized 
by phase contrast microscopy. Lower panels (C and 0): same NPTr cells of panels A and 
B, respecti vely, visualized following IF A. A higher magnification of the cells is shown in 
inset of each panel. 
Figure 2. PCV-2 infectious particles production 
at different cell passages 
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Figure 2. PCV-2 infectious particles production in PK-15A and NPTr cells following five 
consecutive passages. PCV-2 was serially passaged in PK-15A and NPTr cells as described 
in the Material and Methods section of the manuscript. The amount of the infectious viral 
particles recovered after each passage was determined in PK-15A cells by the Karber 
method following IFA to detect PCV-2 infected cells. The initial inoculum (inocul) used to 
infect both cell lines was 4.17 x 102 TCIDso/mL. No significant difference was found 
between PCV-2 infectious particles yields from NPTr and PK-15A infected cells 
(P=0.2832). 
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Figure 3. PCV-2 replication kinetics 
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Figure 3. PCV-2 replication kinetics in PK-15A and NPTr cells. PK-15A and NPTr cells 
. were infected with 1 MOI of PCV -2. At different times pi, the amount of PCV -2 recovered 
from PK-15A and NPTr infected cells was determined in culture medium (or supematant) 
and in cell (or cell pellet). A significant increase in PCV -2 infectious particles production 
started to appear in both cell lines at 48 . hrs pi. No statistical significant difference was 
observed in the overall PCV-2 replication kinetic between PK-15A and NPTr cells 
(P>O.05). Asterix represent a statistical significant difference (P<O.OOl) between the 
amount of virus recovered from the cell culture medium and the cell pellet. 
48 
References 
1. Allan GM, Mc Neilly F, Meehan BM, Kennedy S, Maclde DP, Ellis JA, Clark 
EG, Espuna E, Saubi N, Riera P, Botner A, Charreyre CE (1999) Isolation and 
characterisation of circoviruses from pigs with wasting syndromes in Spain, Denmark 
and Northem Ireland. Vet Microbiol66: 115-123 
2. Allan GM, Ellis JA (2000) Porcine circoviruses: a review. J Vet Diagn Invest 12: 3-
14 
3. Allan GM, McNeiIly F, Meehan BM, Ellis JA, Connor TJ, McNair l, Krakowka 
S, Kennedy S (2000) A sequential study of experimental infection of pigs with 
porcine circovirus and porcine parvovirus: immunostaining of cryostat sections and 
virus isolation. J Vet Med B Infect Dis Vet Public HeaIth 47: 81-94 
4. Balasch M, Segales J, Rosell C, Domingo M, Mankertz A, Urniza A, Plana-
Duran J (1999) Experimental inoculation of conventional pigs with tissue 
homogenates from pigs with post-weaning multisystemic wasting syndrome. J Comp 
Pathol121: 139-148 
5. Chae C (2004) Postweaning multisystemic wasting syndrome: a review of aetiology, 
diagnosis and pathology. Vet J 168: 41-49 
6. Chae C (2005) A review of porcine circovirus 2-assoCiated syndromes and diseases. 
Vet J 169: 326-336 
7. Chang HW, Jeng CR, Liu JJ, Lin TL, Chang CC, Chia MY, Tsai YC, Pang VF 
(2005) Reduction of porcine reproductive and respiratory syndrome virus (PRRSV) 
infection in swine alveolar macrophages by porcine circovirus 2 (PCV2)-induced 
interferon-alpha. Vet Microbiol 
8. Chang HW, Jeng CR, Lin TL, Liu JJ, Chiou MT, Tsai YC, Chia MY, Jan TR, 
Pang VF (2006) Immunopathological effects of porcine circovirus type 2 (PCV2) on 
swine alveolar macrophages by in vitro inoculation. Vet Immunol ImmunopatholllO: 
207-219 
9. Chang HW, Pang VF, Chen LJ, Chia MY, Tsai YC, Jeng CR (2006) Bacterial 
lipopolysaccharide induces porcine circovirus type 2 replication in swine alveolar 
macrophages. Vet MicrobiolllS: 311-319 
49 
10. Cheung AK, Bolin SR (2002) Kineties of porcine circovirus type 2 replication. Arch 
Viro1147: 43-58 
n. Cheung AK (2003) Comparative analysis. of the transcriptional patterns of 
pathogenic and nonpathogenic porcine circoviruses. Virology 310: 41-49 
12. Cheung AK (2003) Transcriptional analysis of porcine circovirus type 2. Virology 
305: 168-180 
13. Cheung AK, Lager KM, Kohutyuk 01, Vincent AL, Henry SC, Baker RB, 
Rowland RR, Dunham AG (2007) Detection of two porcine circovirus type 2 
genotypic groups in United States swine herds. Arch Viro1152: 1035-1044 
14. Chianini F, Majo N, Segales J, Dominguez J, Domingo M (2003) 
Immunohistochemical characterisation of PCV2 associate lesions in lymphoid and 
non-Iymphoid tissues of pigs with natural postweaning multisystemie wasting . 
syndrome (PMWS). Vet Immunol Immunopathol94: 63-75 
15. Clark EG (1997) Post-weaning multisystemie wasting syndrome. In: 28th Annual 
meeting of the American Associati0J? of Swine Practitioners, Quebec City, Canada, 
pp 499-501 
16. Crowther RA, Berriman JA, Curran WL, Allan GM, Todd D (2003) Comparison 
of the structures of three circoviruses: chicken aneniia' virus, porcine circovirus type 
2, and beak and feather disease virus. J Virol 77: 13036-13041 
17. Darwich L, Segales J, Mateu E (2004) Pathogenesis of postweaning multisystemic 
wasting syndrome caused by Porcine circovirus 2: An immune riddle. Arch Virol 
149: 857-874 
18. Dorr PM, Baker RB, Almond GW, Wayne SR, Gebreyes WA (2007) 
Epidemiologie assessment. of porcine circovirus type 2 coinfection with other 
pathogens in swine. J Am VetMed Assoc 230: 244-250 
19. Ellis J, Hassard L, Clark E, Harding J, Allan G, Willson P, Strokappe J, Martin 
K, McNeilly F, Meehan B, Todd D, Haines D (1998) Isolation of circovirus from 
lesions ofpigs with postweaning multisystemie wasting syndrome. Can Vet J 39: 44-
51 
20. Ellis J, Krakowka S, Lairmore M, Haines D, Bratanich A, Clark E, Allan G, 
Konoby C, Hassard L, Meehan B, Martin K, Harding J, Kennedy S, McNeilly F 
50 
(1999) Reproduction of lesions of postweaning multisystemic wasting syndrome in 
gnotobiotic piglets. J Vet Diagn Invest 11: 3-14 
21. Ellis J, ClarkE, Haines D, West K, Krakowka S, Kennedy S, Allan GM (2004) 
Porcine circovirus-2 and concurrent infections in the field. Vet Microbiol 98: 159-163 
22 .. Fernandes LT, Mateu E, Sibila M, Fort M, Andaluz A, McNeilly F, Allan G, 
Sanchez A, Segales J, Stevenson L (2007) Lack of in vitro and in vivo effects of 
lipopolysaccharide on porcine circovirus type 2 infection. Viral Immunol 20: 541-552 
23. Ferrari M, Scalvini A, Losio MN, Corradi A, Soncini M, Bignotti E, Milanesi E, 
Ajmone-Marsan P, Barlati S, Bellotti D, Tonelli M (2003) Establishment and 
characterization of two new pig cell lines for use in virological diagnostic 
laboratories. J Virol Methods 107: 205-212 
24. Gagnon CA, Tremblay D, Tijssen P, Venne MH, Houde A, Elahi SM (2007) The 
emergence of porcine circovirus 2b genotype (PCV-2b) in swine in Canada. Can Vet 
J 48: 811-819 
25. Gagnon CA, dei Castillo JRE, Music N, Fontaine G, Harel J, Tremblay D (2008) 
Development and use of a multiplex real-time quantitative polymerase chain reaction 
assay for detection and differentiation of Porcine circovirus-2 genotypes 2a and 2b in 
an epidemiological survey. J Vet Diagn Invest 20: 545-558 
26. Gilpin DF, McCullough K, Meehan BM, McNeilly F, McNair l, Stevenson LS, 
. Foster JC, Ellis JA, Krakowka S, Adair BM, Allan GM (2003) ln vitro studies on 
the infection and replication of porcine circovirus type 2 in cells of the porcine 
immune system. Vet Immunol Immunopathol94: 149-161 
27. Grau-Roma L, Crisci E, Sibila M, Lopez-Soria S, Nofrarias M, Cortey M, Fraile 
L, Olvera A, Segales J (2007) A proposaI on porcine circovirus type 2 (PCV2) 
genotype definition and their relation with postweaning multisystemic wasting 
syndrome (PMWS) occurrence. Vet Microbiol ln press 
'28. Harding JC (1997) Post-weaning multisystemic wasting syndrome (PMWS): 
preliminary epidemiology and clinical presentation. In: 28th Annual meeting of the 
American Association ofSwine Practitioners, Quebec City, Canada, p 503 
29. Harding JC (2004) The clinical expression and emergence of porcine circovirus 2. 
Vet Microbiol98: 131-135 
51 
30. Harms PA, Hatbur PG, Sorden SD (2002) Three cases of porcine respiratory 
disease complex associated with porcine circovirus type 2 infection. Journal of Swine 
Health and Production 10: 27-30 
31. Kennedy S, Moffett D, McNeilly F, Meehan B, Ellis J, Krakowka S, Allai. GM 
(2000) Reproduction of lesions of postweaning multisystemic wasting syndrome by 
infection of conventional pigs with porcine circovirus type 2 alone or in combination 
with porcine parvovirus. J Comp Patholl22: 9-24 
32. Krakowka S, Ellis JA, Meehan B, Kennedy S, McNeilly F, Allan G (2000) Viral 
wasting syndrome of swine: experimental reproduction of postweaning multisystemic 
wasting syndrome in gnotobiotic swine by coinfection with porcine circovirus 2 and 
porcine parvovirus. Vet Pathol37: 254-263 
33. Krakowka S, Ellis JA, McNeilly F, Ringler S, Rings DM, Allan G (2001) 
Activation of the immune system is the pivotaI event in the production of wasting 
disease in pigs infected with porcine circovirus-2 (PCV -2). Vet Pathol 38: 31-42 
34. Liu J, Chen l, Kwang J (2005) Characterization of a previously unidentified viral 
protein in porcine circovirus type 2-infected cens and its role in virus-induced 
apoptosis. J Virol 79: 8262-8274 
35. Mankertz A, Hillenbrand 8(2001) Replication of porcine circovirus type 1 requires 
two proteins encoded by the viral rep gene. Virology 279: 429-438 
36.' Meehan BM, McNeilly F, Todd D, Kennedy S, Jewhurst VA, Ellis JA,.Hassard 
LE, Clark EG; Haines DM, Allan GM (1998) Characterization of novel circovirus 
DNAs associated with wasting syndromes in pigs. J Gen Virol 79 (Pt 9): 2171-2179 
37. Meerts P, Misinzo G, McNeilly FJ Nauwynck HJ (2005) Replication kinetics of 
different porcine circovirus 2 strains in PK -15 cens, fetal cardiomyocytes and 
macrophages. Arch Viro1150: 427-441 
38. +Vlisinzo G, Meerts P, Bublot M, Mast J, Weingartl HM, Nauwynck HJ (2005) 
Binding and entry characteristics of porcine circovirus ?- in cens of the porcine 
monocytic line 3D4/31. J Gen Virol 86: 2057-2068 
39. Misinzo G, Delputte PL, Nauwynck HJ (2008) Inhibition of endosome-Iysosome 
system acidification enhances porcine circovirus 2 infection of porcine epithelial 
cens. J Viro182: 1128-1135 
52 
40. Nawagitgul P, Morozov l, Bolin SR, Harms PA, Sorden, SD, Paul PS (2000) Open 
reading frame 20f porcine circovirus type 2 encodes a major capsid prote in. J Gen 
Virol81: 2281-2287 
41. Olvera A, Cortey M, Segales J (2007) Molecular evolution of porcine circovirus 
type 2 genomes: phylogeny and clonality: Virology 357: 175-185 
42. Opriessnig T, Thacker EL, Yu S, Fenaux M, Meng XJ, Halbur PG (2004) 
Experimental reproduction of postweaning multisystemic wasting syndrome in pigs 
by dual infection with Mycoplasma hyopneumoniae and porcine circovirus type 2. 
Vet Patho141: 624-640 
43. Opriessnig T, Kuster C, Halbur PG (2006) Demonstration of porcine circovirus 
type 2 in the testes and accessory sex glands of a boar. Journal of Swine Health and 
Production 14: 42-45 
44. Opriessnig T, Meng XJ, Halbur PG (2007) Porcine circovirus type 2 associated 
disease: update on CUITent terminology, clinical manifestations, pathogenesis, 
diagnosis, and intervention strategies. J Vet Diagn Invest 19: 591-615 
45. Racine S, Kheyar A, Gagnon CA, Charbonneau B, Dea S (2004) Eucaryotic 
expression of the nucleocapsid prote in gene of porcine circovirus type 2 and use of 
the prote in in an indirect immunofluorescence assay for serological diagnosis of 
postweaning multisystemic wasting syndrome in pigs. Clin Diagn Lab Immunol 11: 
736-741 
46. Rosell C, Segales J, Plana-Duran J, Balasch M, Rodriguez-Arrioja GM, 
Kennedy S, Allan GM, McNeilly F, Latimer KS, Domingo M (1999) Pathological, 
immunohistochemical, and in-situ hybridization studies of natural cases of 
postweaning multisystemic wasting syndrome (PMWS) in pigs. J Comp Pathol 120: 
59-78 
47. Rovira A, Balasch M, Segales J, Garcia L, Plana-Duran J, Rosell C, Ellerbrok H, 
Ma,nkertz A, Domingo M (2002) Experimental inoculation of conventional pigs with 
porcine reproductive and respiratory syndrome virus and porcine circovirus 2. J Virol 
76: 3232-3239 
53 
48. Sanchez RE, Jr., Meerts P, Nauwynck HJ, Pensaert MB (2003) Change of porcine 
circovirus 2 target cells in pigs during development from fetal to early postnatal life. 
Vet Microbiol 95: 15-25 
49. Sanchez RE, Jr., Meerts P, Nauwynck HJ, Ellis JA, Pensaert MB (2004) 
Characteristics of porcine circovirus-2 replication in lymphoid organs of pigs 
inoculated in late gestation or postnatally and possible relation to clinical and 
pathological outcome of infection. J Vet Diagn Invest 16: 175-185 
50. Segales J, Domingo M, Collell M, Jensen HE, Blanco JL (2003) Pulmonary. 
aspergillosis in a post-weaning multisystemic wasting syndrome (PMWS) afected pig. 
Pig J 52: 41-47 
51. Segales J, Rosell C, Domingo M (2004) Pathological findings associated with 
naturally acquired porcine circovirus type 2 associated disease. Vet Microbiol 98: 
137-149 
52. S9rden S (2000) Update on porcine circovirus and postweaning multisystemic 
wasting syndrome (PMWS). Journal of Swine Health and Production 8: 133-136 
53. Tischer l, Mields W, Wolff D, Vagt M, Griem W (1986) Studies on epidemiology 
and pathogenicity of porcine circovirus. Arch Virol91: 271-276 
54. Todd D, Niagro FD, Ritchie BW, Curran W, Allan GM, Lukert PD, Latimer KS, 
Steffens WL, 3rd, McNulty MS (1991) Comparison of three animal viruses with 
circular single-stranded DNA genomes. Arch Virol117: 129-135 
55. Vincent lE, Carrasco CP, Herrmann B, Meehan BM, Allan GM, Summerfield A, 
McCullough KC (2003) Dendritic cells harbor infectious porcine circovirus type 2 in 
the absence of apparent cell modulation or replication of the virus."J Virol 77: 13288-
13300 
56. Yu S, Opriessnig T, Kitikoon P, Nilubol D, Halbur PG, Thacker E (2007) Porcine 
circovirus type 2 (PCV2) distribution and repli cation in tissues and immune cells in 
early infected pigs. Vet Immunol Immunopathol115: 261-:272 
57. Yu S, Vincent A, Opriessnig T, Carpenter S, Kitikoon P, Halbur PG, Thacker E 
(2007) Quantification of PCV2 capsid transcript in peripheral blood mononuclear 
cells (PBMCs) in vitro. Vet Microbiol123: 34-42 
54 
58. Zhu Y, Lau A, Lau J, Jia Q, Karuppannan AK, Kwang J (2007) Enhanced 
replication of porcine circovirus type 2 (PCV2) in a homogeneous subpopulation of 
PK15 cellline. Virology 369: 423-430 
Differentiai virus replication efficiency of porcine circovirus 2a and 2b in porcine 
trachea and kidney epithelial celllines 
Nedzad Music l, Carl A. Gagnonl,. 
lGroupe de Recherche sur les Maladies Infectieuses du Porc, Faculté de Médecine 
V étérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada, J2S 7C6. 
·Corresponding Author: Carl A. Gagnon, Faculté de médecine vétérinaire, Université de 
Montréal, 3200 rue Sicotte, Saint-Hyacinthe, Québec, Canada, J2S 7C6. Phone: 
 Fax:  E-~ail:  
Short running title: PCV -2b is more efficient than PCV -2a in vitro 
[information retirée / information withdrawn][information retirée / 
information withdrawn]
[information retirée / 
information withdrawn]
[information retirée / information 
withdrawn]
56 
Abstract 
By the end of 2004, the Canadian swine population had experienced a severe 
increase in the incidence of Porcine Circovirus-Associated Disease (PCVAD), a problem 
that was associated with the emergence of a new Porcine circovirus-2 genotype (PCV -2b) 
previously unknown in North America. Thus, it became important to demonstrate that 
PCV -2b strain circulating in Canadian swine herds is more virulent than older PCV -2a 
strain. Infectious DNA clones of PCV-2a and PCV-2b were constructed (pPCV-2a and 
pPCV~2b). The efficacy of pPCV-2a and pPCV-2b transfected yK-15 cells to allow a 
complete virus replication cycle and production of PCV -2 infectious particles was 
evaluated during eight consecutive cell passages. Ten times more PCV -2b infectious viral 
particles were recovered at the 8th cell passage compared to PCV -2a. To corroborate this 
result, the PCV-2a and PCV-2b replication kinetics were evaluated in porcine kidney (PK-
15) and newbom piglet tracheal (NPTr) epithelial cell lines. PCV -2b virus replication 
kinetic was significantly more efficient in both celllines compared to PCV -2a. In 
conclusion, PCV -2b is about 6 to 10 times more efficient than the PCV -2a for the synthesis 
of infectious viral particles in 2 porcine epithelial cell lines. Moreover" since PCV-2 
transmission occurs most likely via the oro-nasal route, the fact that PCV -2b replicates 
more efficiently in tracheal epithelial cells than PCV -2a may contribute significantly to the 
spreading of the virus in the organism at its entry site. Consequently, the virus replication 
efficiency ofPCV-2b compared to PCV-2a could easily explain the increased occurrence of 
PCV AD in Canada during the recent ye~lfs. 
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Introduction 
Postweaning multisystemic wasting syndrome (PMWS) is a swine disease that was 
first recognized in Canada in 1991 [10, 24]. Afterwards, the syndrome was reported 
worldwide [1,2,6,37,41,42]. The disease usually affects 5- to 12-week-old piglets and is 
characterized in part by weight loss, dyspnea, jaundice, and enlarged lymph nodes, as weIl 
as by degeneration and necrosis of hepatocytes, multifocal lymphohistiocytic pneumonia, 
lymphocytic depletion, and multinucleated giant cell formation [24, 45]. The primary 
etiological agent responsible for PMWS has been identified as a circovirus named Porcine 
circovirus-2 (PCV-2; family Circoviridae, genus Circovirus) [1,15,23,31]. Nonetheless, 
the course of PCV -2 infection that will lead to the occurrence of the disease hasbeen 
associated with the presence of other pathogens sl,lch as M hyopneumoniae, Porcine 
parvovirus (PPV), Porcine reproductive and respiratory syndrome virus (PRRSV), and 
Swine influenza virus (SIV) [13, 16, 35, 36, 39]. Furthermore, the disease appearance 
following PCV -2 infection is known to be more complex than initially established because 
PCV-2 can play a pivotaI role in several syndromes [7, 25]. Consequently, the term 
"Porcine circovirus-associated disease (PCVAD)" is now accepted to describe tHe 
syndromes in which PCV -2 plays a role. 
At the end of 2004, the swine industry in the prOVInce of Québec, Canada, 
experienced a significant increase in death rate related to PCVAD [11]. It was hypothesized 
that this emerging problem was caused by the presence of a new type of circulating PCV-2 
strain. This was confirmed by sequencing the entire viral genome of several PCV-2 strains 
originating from PMWS-affected herd [20] . Interestingly, this newly recovered PCV-2 
genotype (named PCV -2b in comparison with the previously circulating genotype named 
PCV-2a) had already been reported in Asia and Europe [12] and had also been recently 
reported in 2007 in the United States [8, 27]. Now, an international consensus has been 
established in regards to the recognition of at least 2 major PCV -2 genotypes circulating 
worldwide [8, 14, 20,22, 34] but there is no universal nomenclature accepted to de scribe 
them. Recently, a nomenclature has been proposed, one that takes into account the 
classification of Gagnon and collaborators (2007) and identifies the two major genotypes 
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(PCY-2a and PCY-2b) as weIl as a third one (PCY-2c) including only three 80's isolates 
that have never been reported afterwards [44]. 
The appearance of the new PCY-2b genotype in Canada could explain the death rate 
increase related to PMWS, but this relationship has to be confinned. Consequently, one of 
the main objectives of the swine industry and health scientists is to establish if there is 
virulence variation between both PCY -2 genotypes (PCY -2a and PCY -2b). 
The aim of the present study was to demonstrate that PCY -2b strain that circulates 
in Canadian swine herds is more virulent in vitro than PCY -2a strain. Thus, the virus 
~eplication efficiency of PCY .. 2a and 2b in porcine kidney epithelial cell line (PK-15) was 
evaluated. Noteworthy, the newborn piglet tracheal (NPTr) epithelial cell line [19] was 
recently discovered to be pennissive to PCY-2 replication [33]. Consequently, the virus 
replication kinetics of PCY -2a and 2b was also evaluated in NPTr cells. The present study 
demonstrates that PCY -2b is 6 to 10 times more efficient than PCY -la for infectious viral 
particles production in two porcine epithelial celllines. 
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Materials and Methods 
Cells. The PK-15A cells [40], a subclone ofPK-15 PCV-l non infected cells, were 
maintained at 37°C in 5% C02 atmosphere in Minimum Essential Medium (NlEM) with 
Earle's salts (Invitrogen Corporation, GibcoBRL, Burlington, ON, Canada), supplemented 
with 10% fetal bovine serum (FBS) (Wisent Inc, St-Bruno, QC, Canada), 300 U/mL of 
penicillin, 300 mg/mL of streptomycin, 0.1 mM non-essential amino acids, 1 mM sodium 
pyruvate and 10 mM HEPES (Invitrogen Corporation, GibcoBRL, Burlington, ON, 
Canada). The NPTr cells [19] were grown at 37°C in 5% C02 in MEM with Earle's salts, 
supplemented with 10% FBS, 300 U/mL of penicillin, 300 mg/mL of streptomycin, ImM 
sodium pyruvate. 
Construction of PCV-2a and.2b infectious DNA clones. Viral DNA genome 
extraction was performed from tissue samples (lungs and lymph nodes) submitted àt the 
molecular diagnostic laboratory of the Faculté de médecine vétérinaire (FMV) of the 
Université de Montréal using the Qiagen QIAamp DNA Mini Kit (Qiagen, Valencia, CA) 
as previously described [21]. The PCV-2 genotype identification was performed with the 
multiplex real-time quantitative polymerase chain reaction (mrtqPCR) as say, as previously 
described [21] and the strains classification was confirmed foUowing sequencing of the 
entire viral genome foUowed by sequence analyses as previously described [20]. A strain 
from each genotype (PCV-2a: FMV-07-0039 and PCV-2b: FMV-06-0732) was selected for 
the construction of PCV -2 infectious DNA clones. The construction of PCV -2a and 2b 
infectious DNA clones was done using the method of Fenaux et al. (2002) [17] with minor 
modifications. Briefly, the extracted DNA was amplified by PCR with PfuUltra High-
Fidelity DNA Polymerase (Stratagene, La JoUa, Califomia, USA). The PCR products 
encompassing the entire viral genome of both strains were produced using the following 
pnmers: F-PCVSAC2 (5'-TCCCCGCGGGCTGGCTGAACTTTTGAAAGT-3'), R-
PCVSAC2 (5'-TCCCCGCGGAAATTTCTGACAAACGTTACA-3') ·and R-PCVKPNI 
(5'-CGGGGTACCAAATTTCTGACAAACGTTACAGGGTAC-3'). Then,. to construct 
infectious DNA clones containing two copies of the entire PCV-2 viral genome, a two steps' 
approach was used. In the first step the PCR product containing the complete PCV -2 viral 
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genome, amplified by F-PCVSAC2 and R-PCVKPNI was cloned into the pCR-Blunt 
plasmid vector using the Zero Blunt PCR Cloning Kit (Invitrogen Canada Inc, Burlington, 
Ontario, Canada) according to the manufacturer's instructions. Similarly, the PCR product 
containing the complete PCV-2 viral genome amplified by F-PCVSAC2 and R-PCVSAC2 
was cloned into the pCR-Blunt plasmid vector. At the 2nd step, the full-Iength PCV-2 
genomic DNA was extracted from the recombinant pCR-Blunt: F-PCVSAC2/R-PCVSAC2 
plasmid followirig SadI restriction enzyme digestion and cloned at the SadI site of the 
recombinant pCR-Blunt: F-PCVSAC2/R-PCVKPNI plasmid. to obtain recombinant 
plasmids containing two copies of the DNA viral genome. The orientation of the two copies 
of the DNA viral genome and the integrity of the PCV -2 infectious DNA clones (pPCV -2a 
and pPCV -2b) were confirmed by PCR, restriction fragment length polymorphisms and 
sequencing. 
PK-15A cells transfection with PCV-2 infectious DNA clones. A monolayerof 
'PK-15A cells at 50% - 70% confluency were trypsinized and centrifuged at 1000 rpm for 5 
min. The cell pellet was washed twice with sterile phosphate-buffered saline (PBS), and 2 x 
106 cells were resuspended in 0.2 mL of electroporation buffer (growth media without 
serum). The cells were mixed with 10 J.lg of DNA of each infectious DNA clones then 
transfected using a Gene Pulser Xcell Electroporation System (BIO RAD Laboratories Inc, 
Life Science Research Division, Mississauga, Ontario, CA). The cells were pulsed twice 
with the following settings: 425V, on, and 25J.lF [30] (exponential decay protocol was used 
with a 0.2 cm Gene Pulser cuvette). Mock-transfected cells with empty pCR-Blunt vector 
were included as controls. The cells were washed twice with sterile PBS buffer and seeded 
in two culture flasks. A flask of mock-transfected cells with empty pCR-Blunt vector was 
included as a negative control. 
Generation of PCV-2a and PCV-2b infectious virus stocks. Following cell 
transfections, the viruses produced were serially propagated into PK-15A cells and were 
purified and concentrated following ultracentrifugation on a 30% sucrose cushion using the 
SW28 Beckman Coulter rotor (Beckman Coulter Canada Inc., Mississauga, Ontario, 
Canada) at 25 000 rpm for 5 hrs. The virus pellets were resuspended ih 2 mL. of a 
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. phosphate buffer saline (PBS) containing 2% fetal bovine serum, and aliquots of the virus 
stocks were then conserved at -70°C for future use. The infectious dose of the virus stocks 
were determined from a 96-well microplate of PK-15A-infected cells following 
immunofluorescence assay (IF A) [40] by the Kfu'ber method as previously described [21]. 
For the calculation of the virus titer, a weIl was considered to be PCV -2 positive if specific 
fluorescence was detected in cells. The virus titer was expressed in tissue culture infectious 
dose 50 per mL (TCIDso/mL). 
Immunofluorescence assay. To determine the in vitro infectivity of the molecular 
DNA infectious clones and to titer the PCV-2 virus stocks, an IFA was performed as 
previously describe with minor modifications [40]. Briefly, to determine the in vitro 
infectivity of the molecular DNA infectious clones, transfected cells (see above) were 
cultivated on eight-well LabTek chamber slides (Nalge Nunc International, Rochester, NY, 
USA). An amount of 3 x 104 PK-15A transfected cells were seeded per weIl. Mock-
transfected cells with non-recombinant pCR .. Blunt vector were included as a negative 
control. The transfected cells were fixed at 72 hrs post transfection with a solution of 4% 
paraformaldehyde (PF A) in PBS for 20 min. Then, the cells were washed three times with 
PBS and they were permeabilized with a solution containing 0.1 % triton X-l 00 in PBS for 
10 min. After incubation with a blocking solution (1 % bovine serum in PBS-T for 20 min), 
cells were incubated with a 1 :200 dilution of the polyclonal PCV -2 porcine serum [40] at 
37°C for 90 min. Then, cells were washed three times with a solution containing 1 % bovine 
serum in PBS-T and incubated with a rabbit anti-pig FITC conjugate antibody (MP 
Biomedicals, Solon, OH, USA) diluted 1 :75 at 37° C for 60 min. After three washing steps, 
cells were visualized· using a DMI 4000B reverse fluorescence microscope. Photographs of 
the cells were taking with a DFC 490 digital camera and the images were analyzed using 
the Leica Application Suite Software, version 2.4.0 (Leica Microsystems). 
PCV -2 infectious viral particles production efficiency. Following transfectionsof 
2x106 PK-15A cells with each infectious DNA clones, cells were divided and seeded in two 
25 cm2 culture flasks. At 96 hrs post infection (Pi), one transfected-flask with each PCV-2 
genotype was· harvested following three cycles of freeze and thaw at ...:... 70°C. After 
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centrifugation at 2000 rpm at 4°C for 10 min, the amount of PCV-2 infectious virus 
particles contained in the supematant was determined, as described ahove. The remaining 
cells of the 2nd flask were trypsinised and seeded in two new 25 cm2 flasks and reinfected 
with a 1:6 dilution of the previously colle.cted PCV -2 virus. The same protocol was ·carried 
out 7 times for subsequent passages. Mock-transfected cells were included as controls. 
PCV-2 replication kinetics in PK-15A and NPTr cells. 1 x 105 PK-15A and NPTr 
cells were infected in suspension with (0.5 MOI of PCV -2a and 2b produced from the 
infectious DNA clones. Following a 4 hrs absorption period, the virus inoculum was 
removed and cells were washed five times with PBS before adding fresh culture medium. 
At different times post infection (0, 4, 6, 12, 18, 24, 48, 72, 96 and 120 hrs pi), the infected 
cell cultures were collected, centrifuged at 2000·rpm at 4°C for 10 min, then cell pellets and 
supematants were stored at -70°C until virus titration. Before titration, aU ceU pellets and 
supematants were frozen and thawedthree times tofree infectious viral particles, and ceU 
debris were discarded after centrifugation at 2000 rpm at 4°C for 10 min. Mock-infected 
cells were included in each experiment as control. AU experiments were performed two 
times in triplicate. 
Statistical analyses. The statistical analyses were realized using the GraphPad 
Prism version 4 software. The regular two-way ANOV A combined with the Bonferroni 
post-tests models were used to determine if there were statisticaUy significant differences 
between PCV -2a and 2b in regards to their efficiency to replicate in PK-15A and NPTr ceU 
lines. 
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ResuUs 
Construction of PCV -2a and PCV .. 2b infectious DNA clones. The complete 
genomes of both PCV -2 viruses were ampllfied by PCR. Two copies of the PCV-2 
genomes were ligated in tandem into the pCR-Blunt plasmid vector to pro duce the PCV-2a 
and PCV -2b infectious DNA clones (named pPCV -2a and pPCV -2b, respectively). The 
ability of pPCV-2a and pPCV-2b to express the. viral capsid protein (Cap) was determined 
in vitro following transfection of PK-15A cells with pPCV-2a and pPCV-2b and its 
detection by IF A. Both intrac~oplasmic and intranuclear positive signaIs were found in 
pPCV-2a and pPCV-2b transfected PK-15A cells with a higher amount of antigen detected 
in the nucleus as illustrated in Fig. 1. The ratio of the PK-15A transfected cells expressing 
the. PCV-2 antigens was very similar for both genotypes (Fig. 1). The PK-15A cells 
transfected with the empty pCR-Blunt vector remained negative for PCV-2 antigen by IFA. 
(Fig. 1). 
PCV-2 infectious viral particles production efficiency. Following the 
confirmation that the pPCV-2a and pPCV-2b transfected PK-15A cells were able to express 
PCV -2 proteins, the efficacy of the transfected PK-15A cells to allow a complete virus 
replication cycle and infectious viral particles production was determined. The amount of 
. . 
PCV-2 virus produced in PK-15A transfected cells was evaluated during eight consecutive 
cell passages (Fig. 2). At the beginning, the cells were transfected with same amount of 
PCV-2 DNA infectious clones (10 jlg). At the first cell passage (i.e. transfected cells), 103 
TCIDso/mL infectious viruses were recovered from PK-15A transfected cells for both 
genotypes (Fig. 2). Furthermore, it was noticed that the production of PCV -2 infectious 
viral particles was less efficient during the 2nd and 3rd cell passages~ However, at the 4th cell 
passage, the amount of PCV -2 infectious viral particles recovered was identical to the 
, 
amount recovered at the first cell passage and started to increase at that point üntil the end 
of the experiment, i.e. until the 8th cell passage, for both PCV -2 genotypes. At the 8th cell 
passage, the amount of PCV -2 virus recovered from cell lysates was 104 TCIDso/mL and 
lOS TCIDso/mL for PCV-2a and PCV-2b, respectively. Consequently, 10 times more PCV-
2b infectious viral particles were recovered at the 8th cell passage compared to PCV -2a 
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(Fig. 2). Furthelmore, this latest result was confirmed by IF A in PK-15A infected cells with 
PCV-2a and 2b cell lysates of the 8th cell passage (Fig. 3). As illustrated in Fig. 3, the 
amount of cells expressing the Cap protein was higher in PCV -2b infected cells compared 
to PCV-2a infectedcells when the· same amount of inoculumwas used. In addition, the 
cells infected with the PCV -2b 8th cell passage lysate 10-2 dilution has a similar number of 
IF A positive cells than the 10-1 dilution of PCV -2a 8th cell passage lysate infected cells 
(Fig. 3), which furthermore indicated that the PCV -2b virus production was higher 
compared to PCV-2a virus production. ThePK-15A mock infected cells remained negative 
for the expression ofPCV-2 antigen (Fig. 3). 
PCV-2 replication kinetics in PK-15A and NPTr ceUs. To confirm the previous 
results, the PCV-2a and PCV-2b replication kinetics were evaluated in PK-15 and NPTr 
cells. Consequently, the amounts of virus yields in cell culture medium (or supematants) 
and in cells (or cell pellets) were determined at different times pi (Fig. 4). PCV-2 infectious 
partic1es production was clearly demonstrated in both porcine. epithelial cell lines since the 
\ amount of virus recovered in PK-15A infected cells at120 hrs pi was 790 and 3702 times 
higher compared at 4 hrs pi in cell pellets for PCV -2a and PCV -2b, respectively (Fig. 4). 
Similarly, the amount of virus recovered in NPTr infected cells at 120 hrs pi was 1000 and 
4444 times higher compared to 4 hrs pi in cell pellets for PCV -2a and PCV -2b, respectively 
(Fig. 4). At 72 hrs pi and until the end of the experiment, the. amount ofPCV-2a and PCV-
2b recovered from the cell fractions in both cell lines was 10 times higher compared to the 
amount of viruses recovered from the supematant or cell culture medium (P<O.OOI) (Fig. 
4), suggesting that PCV-2 was weakly released from infected cells. Overall, the amount of. 
PCV-2b recovered in both infected celllines was 3, 6 and 6 times higher compared to PCV-
2a infected cells at 72, 96 and 120 hrs pi, respectively (P<O.OOI) (Fig. 4), indicating that 
PCV -2b was more efficient compared to PCV -2a in regards to virus replication and 
subsequently for infectious viral particles production. In addition, there is no significant 
difference in the amount of the virus yields for both PCV -2 genotypes between both cell 
lines (P>0.05) (Fig. 4). 
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Discussion 
Beside genomic analysis results, it is the first time that phenotypic difference 
between PCV -2a and PCV -2b virus es such as in vitro virus replication kinetic is reported. 
In the present study, PCV-2b virus has been shown to be 6 to 10 times more efficient than 
PCV-2a for Ï:nfectious viral particles production (Figures 2 and 4). Moreover, this latest 
result has been obtained in 2 permissive porcine cell lines, the PK-15 and the newly 
discovered NPTr tracheal epithelial cells [33], which further indicates that this phenotypic 
characteristic could possibly be applied to several other porcine cell types beside kidney 
cells. Since PCV -2 transmission is considered to occur most likely via the oro-nasal route, . 
it was interesting to found out that PCV -2b virus replicates more efficiently in NPTr cells, 
which may contribute significantly to the spreading of the virus in the organism at its entry 
site. Several studies have shown a correlation between PCV -2 viral loads with the severity 
of histopathological lesions and disease expression [3, 9, 21, 26, 28, 29, 43]. Thus, it is 
conceivable to correlate this finding with the fact' that if virus replication of PCV-2b is 
more efficient then it should increase the tissues viral load and subsequently favor the 
appearance of PCV AD. In addition, it is interesting to pin point that PCV ~2b has appeared 
at the same time than the PCV AD prevalence increases in Canada [4, 5, 11]. Moreover, a 
recent retrospective study showed a statistically significant PCV AD frequency increase of 
characteristic histological lesions observed in lymph node, spleen, lung, small intestine, 
colon, and kidney, in PCV-2b infected animaIs compared to pigs infected with PCV-2a 
strains [5]. As an example, there is 9.33 times more chances to observe depletion of 
lymphoid follicles in lymph no de of animaIs infected with PCV -2b strains compared to 
animaIs infected with PCV-2a strains [5]. In addition, viral burden in lymph node, which 
has been estimated with immunohistochemistry (IHC) staining, was ~lso significantly 
increased in pigs infected with the PCV-2b strains compared to PCV-2a strains [5]. 
Because these results were derived from a retrospective analysis of clinical cases submitted 
to Canadian diagnostic laboratories, the conclusion may be biased but it strongly suggests 
that PCV -2b virus is more virulent than PCV -2a virus, and it is supported by the fact that 
PCV -2b virus replication is more efficienuhan PCV -2a virus replication (Figures 2 and 4). 
On the other hand, a recent study has demonstrated no difference in virulence between 
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PCV -2a and PCV -2b in a conventional pig. infection model meaning that the PCV AD 
outbreaks seen in recent years cannot be explained only by the introduction of more 
virulent strains of PCV-2 [38]. Interestingly, seqùence analysis has demonstrated that the 
PCV -2/0RF2 gene sequence in samples collected from Swedish pigs, prior to and during 
an outbreak of enzootic PMWS, could be classified into three main genogroups designated 
SOI, S02 and S03 [46]. Ofparticular significance, one of the genogroups (SOI) has never 
been associated with PMWS in the field· whereas another (S03) was predominantly 
recovered from farms fo.1lowing outbreaks of PMWS [46]. In addition, sequence analysis 
revealed that Canadian PCV -2b strains associated with PCV AD outbreaks fall clearly 
within S03 genogroup (>98.5% ORF2 nucleotide sequence identities) and further supports 
the hypothesis of the authors [46]. 
In a previous study, the replication kinetics of seven different PCV-2 strains were 
compared in PK-15 cells [32]. It was demonstrated that the production of infectious viruses 
in PK -15 cells can be more efficient for sorne strains (like Stoon-1O 1 0) compared to other 
strains (like strain 1121) but only strains of the same genotype (PCV -2a) were compared 
[32]. Furthermore, the· total maximum amount of recovered viruses was 100 lower 
compared to the present study. Small differences in the genetic code could easily be 
involved in the differences observed in regards to· virus replication efficienci As an 
example, it was demonstratred that PCV-2 passaged 120 times in PK-15 cells (VP120) 
replicated more efficiently than wild-type virus that had been passaged only once (VP 1) 
[18]. Two amino acids mutations were identified in the Cap protein between VP1 and 
VP 120 viruses; proline to alanine at position 110 (P 11OA) and arginine to serine at position 
191 (R19IS), which 'indicate that ORF2 gene could be involved in virus replication 
efficiency. The most variable gene between the PCV-2a and PCV-2b genotypes is the 
ORF2 gene encoding the Cap protein, with an amino acid (aa) sequence identity varying 
from 88% to 94% between genotypes [20]. 
In conclusion, PCV -2b is about 6 to 10 times more efficient than the PCV -2a for the 
synthesis of infectious viral particles in two porcine epithelial cell lines. It could easily 
explain the increased occurrence of PCV AD during the recent years. The fact that PCV -2b 
virus replication is more efficient in two porcine celllines emphasizes the importance of the 
present study. Since only one virus in each PCV-2 genotype has been studied, it will be 
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interesting to evaluate several strains of each genotype to generalize the present findings. 
Furthermore, experimental infection of susceptible pigs with PCV -2a and PCV -2b will be 
necessary to establish with certainty any relationship between the PCV AD severity and 
PCV -2 genotypes. 
68 
Acknowledgments 
The authors thank Dr Mario Jacques (Faculté de médecine vétérinaire, Université de 
Montréal) and Dr. M. Ferrari (Instituto Zooprofilattico Sperimental, Brescia, Italy) for 
pro vi ding the NPTr cellline .. The authors are grateful to Cynthia M. Guilbert and Sanela 
Music for critically reviewing the manuscript. This work was supported by the National 
Sciences and Engineering Research Council of Canada (NSERC) discovery grants (to 
CAG), the Fédération des producteurs de porcs du Québec (FPPQ), the Centre 
d'insémination porcine du Québec Inc. (CIPQ) and the Conseil pour le développement de 
l'agriculture du Québec (CDAQ). Nedzad Music was the recipient of a master research 
scholarship from the Fonds québécois de la recherche sur la nature et les technologies 
(FQRNT). 
) 
r 
... 
-
-
.. 
N 
>-U 
Q., 
.:: 
N 
1 
> U 
Q., 
c.. 
69 
Figure 1 
PK-15A tnmsfected ceUs 
. Figure 1. Detection of PCY·2 infectious DNA clones' transfected PK-15A cens by 
immunofluorescence assay. PK-j5A cells werè transfected with.PCV-2a and 2b infectious 
DNAc10nes (pPCV-2a in panel Band pPCV-2b in panel'C, respectively) or with the erilpty 
pCR-Blunt vector (panel A: pCR-Blunt). Transfected cells weie fixed at 72 hrs pi with a 
4% PFA solution followed by incubation with pô'rcine polyc1onal anti-PCV-2 serum and 
stained with anti-porcine FITC-conjugated secondary antibody. The ratio of the. PK-15A 
transfected cells expressing the PCV-2 antigens was similar for both genotypes. The PK-
15A pCR-Blunt transfected cells remained negative for PCV-2 antigen by IFA. 
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Figure 2. PCV -2 infectious viral particles production in PK-15A transfected cells. At 
passage nurnber 1, the cells were transfected with same amount (IOllg of DNA) of PCV-2 
DNA infectious clones (pPCV-2a and pPCV-2b). Then,produced virus (PCV-2a and PCV-
2b) was serially passaged in PK-15A cells as described in the Materials and Methods 
section of the manuscript. The amount of the infectious viral particles recovered after each 
passage was determined in PK-15A cells by the Karber method following IFA to detect 
PCV-2 infected cells. Ten times more PCV-2b infectious viral particles were recovered at 
the 8th cell passage compared to PCV -2a. 
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Figure 3 
Figure 3. Detection of PK-15A cells infected with the ceIllysates of the 8th cellpassage. 
'. 1 . 
PK-15A cèlls were fixed at 72 hrs pi with a 4% PFA solution followed by incubation with 
porcine polyclonal' anti-PCV -2 serum and stained with anti-porcinç FITC-conjugated ' 
secondary antibody. The amount of cells expressing the,Cap protein was higherin PCV-2b 
. \ ' 
infected cells compared to PCV-2a infectedfells at the sarne virus dilution irioculums. The' 
cells infected with a 10-2 dilution of PCV -2b 8th cell passage lysate has a similar nurnber of 
IF A positive cells than the cells infected with a 10-1 dilution of PCV -2a 8th cell passage 
Iysate. The PK-15A mock infected cells remained negative for the expression of PCV-2 
antigen. 
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Figure 4 
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Figure 4. PCV-2 replication kinetics in PK-15A and NPTr infected ceUs. PK-15A and 
NPTr ceUs were infected in suspension with 0.5 MOI ofPCV-2a and PCV-2b. At different 
times pi, the amount of PCV-2 recovered from PK- 15A and NPTr infected ceUs was 
detennined in culture medium (or supernatant) and in ceU (or cell pellet). At 72 hrs pi and 
until the end of the experiment, the amount ofPCV-2a and PCV-2b recovered from the ceU 
fractions in both ceU lines was 10 times higher compared to the amount of viruses 
recovered from the supernatant or celI culture medium (P<O.OOl). The amount of PCV -2b 
recovered in both celllines was 3, 6 and 6 times higher compared to PCV -2a at 72, 96'and 
120 hrs pi, respectively (*P<O.OOl). 
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At the end of 2004, the swine industry in the province of Quebec experienced a 
significant increase in death rate related to PCVAD. At that time, no statistical analysis 
supported this observation and no data indicating the extent of the increase in death rate 
was available. Consequently, an epidemiological survey that included producers (for a total 
of 245 producers) that annually sold on the market 15% (1 000 000 pigs) of the entire 
Quebec pig production was conducted to provide valuable information on the severity of 
the mortality increase [42]. This study included aIl types of production and revealed an 
increase of 2.39% in the mortality rate in Quebec pig farms in 2005 (7.57%) compared to 
2004 (5.18%). More specificaIly, weaning-finishing production had a mortality rate average 
of 7.53% in' 2005 compared to 5.31% in 2004. Similady, finishing production had a 
mortality rate average of7.66% in 2005 compared to 4.88% in 2004. Interestingly, 56% of 
the producers indicated that their production had a clinical, pathologic, or laboratory 
diagnosis of PCVAD at the time of the survey, which was held at the 'end of 2005 [42]. It 
was hypothesized that this emerging problem was caused by the presence of a new type of 
circulating PCV -2 strain. This was confirmed by sequencing the entire viral genome of 
several PCV-2 strains originating from PMWS-affected herd [63]. The appearance of the 
new PCV -2b genotype in Canada could explain the death rate increase related to PCV AD. 
To confirm this relationship, one general objective and four specific objectives were 
formulated iIi this study. The general objective of the present study was to establish 
whether the new genotype (PCV-2b) is more pathogenic than the old genotype (PCV-2a) 
and therefore determine whether the increase, since 2004, in the occurrence of the disease 
associated with PCV -2 (PCV AD) can be explained by the emergence of the new genotype. 
Specific objectives were: (1) to construct various infectious molecular DNA clones with the 
genome sequence of new and old genotypes; (2) to evaluate in vitro viral replication of the 
different PCV-2 viruses; (3) to evaluate in vivo pathogenesis and (4) to improve diagnostic 
tests for detection and differentiation of the PCV -2 new genotype from the old one. In our 
work, we had significant results and progress in three of our objectives. Unfortunately, in 
vivo work did not produce any satisfying results. 
Considering the fact that the PCV -2 VIruS is recognized as a virus whose 
propagation in cell culture is not very efficient, it was of the utmost importance to proceed 
in a certain way that would encourage virus production in larger quantities to eventually be 
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able to perform experimental infections on the piglet. Consequently, the reverse genetics, as 
described by Fenaux and his collaborators (2002), were the applied method to fulfill the 
criteria [56]. Two copies of the PCV-2 genomes were ligated in tandem into the pCR-Blunt 
plasmid vector to pro duce the PCV -2a and PCV -2b infectious DNA clones as previously 
described [56] with 'minor modification, and they were shown to be infectiousin vitro when 
transfected into PK-15 cells (article # 2, Fig. 1). The. construction of an infectious PCV-2 
molecular DNA clone and the demonstration of infection by direct transfection in vitro and 
in vivo should be very advantageous for future PCV-2 studies. Using recombinant plasmids 
constructed in vitro to test different regions or genes of PCV -2 for their roles in virus 
replication and pathogenesis, this in vitro-in vivo transfection system will enable us to study 
the structural and functional relationship of PCV -2 genes. The replication aild pathogenesis 
of PCV-2 can be studied without having to produce infectious virus stocks by propagating 
PCV -2 in cell cultures. This is advantageous, as seriaI cell culture passages may select for 
viral variants [6]. Another advantage ofusing cloned PCV-2 genomic DNA, instead of live 
virus, is its relative ease for quantitation of the inoculation dose. The amount of the cloned 
PCV-2 DNA used for inoculation can be easily determined by a spectrophotometer, 
whereas the dose of live PCV-2 virus requires infectivity titration in cell cultures and 
confirmation of infection by IF A. Finally, direct transfection of the cells with c10ned PCV-
2 plasmid DNA eliminates the problems associated with the presence of other indigenous 
swine agents that could be present in viral stock. 
À new, the newbom piglet tracheal (NPTr) epithelial cell line [61], was found to be 
permissive to PCV -2 (article # l, Fig 1). This finding is interesting because until now, there 
was only one type of immortalized cellline (the porcine kidney epithelial cells) known to 
permit infectious viral particles production [106, 142]. Both cells, PK-15 and NPTr, were 
identical in the regards to their efficacy t6 pro duce infectious viral particles (article # 1, Fig. 
3; article # 2, Fig. 4), suggesting that new cell line couldbe used for vaccine production. 
Unfortunately, this remains an open question, because NPTrcells contain porcine 
endogenous retro virus (PERV) and this is not allowed by the Food and Drug 
Administration (FDA) guidelines [61]. Furthemore, the NPTr cells can be a useful tool for 
virus isolation in a virology diagnostic laboratory since they permit the repli cation of a 
large variety of swine viruses [61]. Nonetheless, the NPTr cell line is now the second 
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immortalized cell line known to allow PCV -2 infectious viral particles production and in 
that regards, this cellline can be used as a new in vitro model to study PCV -2 pathogenesis. 
Work is now in progress to determine ifthere is any difference between NPTr and PK-15 
cells following PCV -2 infection such as cytokine modulation. 
Beside genomic analysis results, it is the first time that phenotypic difference 
between PCV -2a and PCV -2b viruses such as in vitro virus replication kihetic is reported. 
In the present study, PCV-2b virus has been shown to be 6 to 10 times more efficient than 
\ 
PCV-2a for infectious viral particles production (article # 2, Fig. 2 and 4). The PCV-2 
transmission is considered to occur most likely via the oro-nasal route because 
experimental infection studies, which have mainly used the intranasal route of inoculation, 
support that idea [128]. Then, it was interesting to find that PCV -2b virus replicates more 
efficiently than PCV-2a virus in NPTr cells. In vivo, it was demonstrated that tracheal 
epithelial cells of PCV AD sick animaIs may express a high amount of PCV -2 antigens [20]. 
Taken together, these results suggest that tracheal epithelial cells could possibly contribute 
to the spreading of the virus in the organism by increasing the viralload at its entry site, but 
in vivo experiment will have to be conducted to confirm this hypothesis. Several studies 
have shown a correlation between PCV -2 viralloads with the severity of histopathological 
lesions and disease expression [18, 64, 73, 90, 152]. Thus, it is conceivable to correlate this 
finding with the fact that if virus replication of PCV -2b is more efficient, then it should 
increase the tissues viral load and subsequently favor the appearance of PCVAD. 
Moreover, a recent retrospective study showed a statistically significant PCV AD frequency 
increase with characteristic histological lesions observed in PCV -2b infected animais 
compared to pigs infected with PCV-2a strains [23]. Because these results were derived 
from a retrospective analysis of clinical cases submitted to Canadian diagnostic 
laboratories, the conclusion may be biased but it strongly suggests that PCV -2b virus is 
more virulent than PCV -2a virus, and it is supported by the fact that PCV -2b virus 
replication is more efficient than PCV-2a virus replication as reported in this study. On the 
other hand, a recent study has demonstrated no difference in virulence between PCV -2a and 
PCV -2b in a conventional pig infection model meaning that the PCV AD outbreaks seen in 
recent years cannot be explained only by the introduction of more virulent strains ofPCV-2 
[129]. Small differences in the genetic code could easily be involved in the differences 
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_ observed in regards to virus replication efficiency. As an example, it was demonstrated that 
PCV-2 passaged 120 times in PK-15 cells (VP120), replicated more efficiently than a wild-
type virus that had been passaged only once (VP1) [58]. Two amino acids mutations were 
identified in the Cap protein between VP1 and VP120 viruses; proline to alanine at position 
110 (PlI OA) and arginine to serine at position 191 (R191 S), which indicates that the ORF2 
gene. could be involved in virus replication efficiency. In addition, the most variable protein 
between the PCV-2a and PCV-2b genotypes was the Cap protein, which is encoded by the 
ORF2 gene, with an amino acid (aa) sequence identity varyirig from 88% to 94% between 
genotypes [63]. 
In order to develop a PMWS infection model, Yorkshire X Landrace SPF (specific 
pathogen free) weaned piglets of a one week age originated from a matemity recognized to 
be free of the major porcin,e pathogens such as PRRSV, M hyopneumoniae, influenzavirus, 
TGEV / PRCV and PPV were purchased. At their arrivaI, blood samples were collected and 
serological and PCR tests were executed to ascertain their health status and confirm the 
absènce of pathogens susceptible to influence the experimental infections. The piglets were 
housed for three weeks before infection procedure. Two days before thè experimental 
infections, blood samples were taken to establish their negative status in regard to PCV -2. 
Experimental infections were conducted as described by Krakowka and al. (2001) 
and Nielsen and al. (2003) [86, 117]. Therefore, there were four experimental piglet groups, 
each divided as follows: 1) non-infected piglets, 2) non-infected and injected with 
KLHlICF A, 3) piglets infected with PCV -2b alone and 4) piglets infected with PCV -2b and 
injected with KLH / ICF A. The advantages of KLHlIFCA as an immuno-stimulator which 
favours PCV -2 infection have already been demonstrated in few experimental infection 
studies [128]. During the study, the animaIs were monitored daily for clinical signs of 
disease. Each week, blood samples were collected, and rectal temperatures and body weight 
were recorded. The animaIs were to be humanitarianly sacrificed at the 35th day post-
infection. Various organs were taken (lungs, mediastinal and tracheobronchial lymph 
nodes, intestines, kidneys, liver, spleen) to evaluate and quantify 'the histopathological 
lesions as well as to determine the presence of a PCV-2 antigen in those lesions (essential 
condition to confirm PCV AD). 
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Unfortunately, in vivo work did not pro duce any satisfying results. Four 
experimental infections were carried out, each time with minor modifications in the 
experimental design. The corrections we made were based on our own experience, and· on 
new results and publications in other laboratories. In the. end, we were not able to develop a 
constant model for PMWS disease production. During the four experimental infections, 26 
piglets were infected and only one of them has developed PCV -2 characteristic lesions 
without clinical signs. This was a too low success rate to be considered as an efficient 
infection model. In conclusion, this project is to be continued and for its success, a more 
efficient infection model has to be éiaborated. The possible solutions are to change the 
infection protocol: 1) either the animal type such as CDCD, gnotobiotic or 2) by the 
addition.of a cofactor such as PRRSV, PPV, etc. 
Following the development of a good infection model, it would have been possible 
to study the pathogenecity and virulence of PCV -2b compared to PCV -2a in infected 
animaIs. 
Finally, in this study, a new multiplex real-time quantitative polymerase chain 
reaction (mrtqPCR) assay was developed to sensitively identify· and differentiate PCV-2 
viruses in clinical samples [64]. With the exception of the conventional PCR assay 
-developed previously [79], all other PCR assays reported until now did not differentiate 
PCV-2 genotypes [18, 38, 93, 172]. Moreover, the conventional PCR diagnostic test 
reported previously [79] required 2 PCR reactions to identify both genotypes whereas only 
1 reaction is required in the our mrtqPCR [64]. Previous results indicated that the gene that 
best distinguishes PCV ~2a from PCV -2b was the ORF2, with a nt sequence identity varying 
from 88-94% between both genotypes [63]; 
Afterwards, a retrospective epidemiologic survey was conducted usmg PCV-2 
mrtqPCR-positive cases that were submitted to the molecular diagnostic laboratory of the 
Faculté de médecine vétérinaire (FMV) of the Université de Montréal to determine the 
prevalence of PCV -2 genotypes and to establish if other viral or bacterial pathogens were 
associated with the clinical disease. Furthermore, because PCV-2 antigen detection in 
microscopic lesions by IHC is one of the three criteria used for the diagnosis of PCV AD 
cases [152, 158],the survey was conducted to determine-the relationship between the PCV-
2 IHC results and the PCV .. 2 viral load with PCVAD. The relationship between PCV-2 
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viral load and clinical expression of PCV AD confirms results previously reported [18, 
119]. Higher is the PCV -2 viral load in tissue samples, higher is the probability to have 
PCVAD [64]. In the present study, the prevalence of PCV-2b virus was very high, as 
previously reported [63]. In fact, 95.9% of the submitted cases were infected with PCV- 2b 
virus, even though 40.5% of those submitted cases had no clinical sign and microscopic 
lesion related to PCV AD. This suggests that not aIl animaIs infected with PCV -2b virus 
may develop PCV AD [64]. However, the difference observed between the presence of 
PCV AD and the number of PCV -2b cases may be due to the stage and time course of 
infection when the tissue samples were collected. The course of PCV -2 infection that will 
lead to the occurrence of the disease has been associated with the presence of other 
pathogens, such as M hyopneumoniae, PPV, PRRSV, and SIV [49, 54, 128, 133]. Thus, it 
was not surprising to find at the preliminary stage of data analysis, that a significant 
association existed between the presence ofPRRSV and the appearance ofPCVAD [64], as 
previously reported. Similar to the correlation between PCV -2 viralload and PCV AD, there 
was a significant association between.PRRSV viralload and the appearance of PCV AD. In 
contrast, the multivariate polytomous logistic regression analysis suggested that the 
presence and viral load of PRRSV had no significant effect on the PCV AD score, when 
both PCV-2 viralload and IHC result parameters are included in the regression model [64]. 
This suggests that PRRSV may be less involved as a cofactor responsible for the induction 
of PCVAD than expected [54, 133]. The most interesting finding was the significantly 
increased odd ratios (ORs) of isolating two major porcine respiratory pathogenic bacterias, 
A. pleuropneumoniae and S. suis pathogenic serotypes (1/2, 1, 2, 3, 4, and 7), as PCV-2 
viral load increases. Yet, despite a good statistical relationship between .A. 
pleuropneumoniae, S. suis pathogenic serotypes, and PCV -2 viral load, it is impossible to 
determine if those bacterial pathogens increased the risk of PCV AD development or if they 
colonized the host respiratory tract after PCV -2 infection. 
v. CONCLUSION 
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Postweaning multisystemic wasting syndrome (PMWS) is a major disease that 
poses a significant threat to the economics of global swine industry and more recently in 
North America. It is expected that results from this study will contribute to better 
understanding the virulence variation between both PCV -2 genotypes (PCV -2a and PCV-
2b) and can help swine industry and health scientists to deal with this important issue. 
Results from the first part of this thesis demonstrate that the newbom piglet tracheal 
(NPTr) immortalized epithelial cellline is permissive to PCV-2 replication. This suggests 
that the epithelial cells of the respiratory tract of swine can be the primary cell target for 
PCV -2 replication and could subsequently provide a way of entry in swine. In addition, the 
NPTr cellline could be used as a new in vitro model for studying PCV -2 pathogenesis and 
can be a useful tool for virus isolation in a virology diagnostic laboratory. 
Furthermore, it was shown that the PCV -2b is about 6 to 10 times more efficient 
than the PCV -2a for the synthesis of infectious viral particles in two porcine epithelial cell 
lines. This finding could explain, at least in part, the increase in the occurrence of PMWS 
during recent years. The fact that PCV -2bvirus replication is more efficient in two porcine 
cell lines emphasizes the importance of the present study. Experimental infection of 
susceptible pigs with PCV -2a and PCV -2b will be necessary to establish with certainty any 
relationship between the PMWS severity and PCV -2 genotypes. 
Moreover, the infectious DNA clones constructed in this study could be used for 
mutant virus production. This would enable us to study the amino acids (aa), which could 
be responsible for the pathogenesis alteration between PCV -2b and PCV -2a. 
It should be emphasized that in vivo experiments have not provided the expected 
results. Therefore, it is strongly recommended to repeat in vivo infection using the 
experience acquired during this study and other recent studies in order to develop a more 
efficient experimental infection model. 
In the framework of this study, a multiplex real-time qu~titative polymerase chain 
reaction (mrtqPCR) assay that could sensitively and specifically identify and differentiate 
PCV -2 genotypes was developed. A retrospective epidemiological survey that used the 
mrtqPCR assay was performed to determine if cofactors could increase the risk of 
developing PMWS. Relationship established between PCV -2 viral load and clinical 
expression of PMWS confirms results previously reported. Higher is the PCV -2 viral load 
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in tissue samples, higher is the probability to have PMWS. In addition, it has been 
demopstrated that mrtqPCR could replace the IHC assay to confirm PCVAD èases. Since 
the odds of isolating A. pleuropneumoniae and pathogenic S. suis is significantly higher 
when the PCV -2 viralload increases, new experiments are now being conducted to evaluate 
the impact of PCV -2 and the mechanisms involved in the bacterial colonization of the 
swine respiratory tract. 
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DevelopmeIit and lise of à multiplex, real~timequantitative poly#}eFase 
chain reaction assay for detection and differentiation of Porcine, 
circovirus-2 genotypes' 2a and 2b in an epidemiological survey , 
CarI A. Gagnon,I Jérome R. E. dei Castillo, Nedzad Music, Guy Fontaine, JoséeHatel, 
Donald Tremblay 
Abstract. By the end of 2004, the Canadian swine population had experienceda severe increase ,in the 
incidence of Porcine circovirus-associated;,'disease (PCVAD);' 'a ,problèm that was asso,ciated wit,h:,t1ié" 
emergence of a new Porcine circovirUs-2 genotype (PCV-2b),previbüslyunrécovered in North Ainei'ica::fhu~;' ~" 
it became important to develop a diagnostic'tooi;thatcould difTereniiate betweeIi. tiieold and new circuJating 
genotypes (PCV-2a and PCV-2b, respectively), Conseguently, a multiplex real~time:qllanîitative polymerase 
chain reaction (mrtqPCR) as say that could sensitively and specifically identify and differentiate PCY-2 
genotypes was developed, A retrospective epidel}liologic survey that used the mrtqPCR assaywas performéd 
to determine if cofactors could affect the riskof PCVAD. From 121 PCV-Z-positive cases gathered for this 
study, 4.13%, 92.56%, and 3,31% were positive for PCV-2a, PCV-2b, and both genotypes, respectively. In a 
data analysis using univariate logistic regressions, the PCV AD-compatible (PCVAD/c) score was significantly 
associated with the presence of Porcine reproductive and respiratory syndrome virus (PRRSV), PRRSV viral 
load, PCV-2 viral lo'ad, and PCV~2 immllnohistochemistry (IHC) results. Polytomous logistic regression 
analysis revealed that PCVAD/c score was afrected by PCV-2 viraI load (P ~ 0.0161) and THC (P = 0.0128), 
but not by the PRRSV variables (P > 0.9), ",hicli suggests that mrtqPCR in tissueisinelia,ble alternative to 
IRC. Logistic regression analyses revealed"that"PCV-2 increased ,the odds"ratio of isolMing, 2'major swine 
pathogens of the respiratory tract, Actinobacilll!s,pleuropneumoniae and Streptocoècus suis .serotypes 1/2, l, 2; 
3,4, and 7, which are serotypes commonlyass()ciated with,c1inicaldiseasës. ' 
Key words: Epidemiologic survey; genotyping;, molecular diagnostic test; Porcine circovirus-2. 
Introduction i'i is a smaH nonenvelopedvirus that possesses a single-
Postweaning multisystemic wasting syndrome 
(PMWS) is a disease of swine initially' identified in 
Canada ln 1991,13 Now, it is known as a worldwide 
disease, and out breaks have been reported.in swine 
herds of North and South America, Europe, and Asia.7 
The disease affects 5- to 12-week-old. pigIets and is 
characterized in part by weight loss, dyspnea, jaundice, 
and enlarged Iymph nodes, as weil as by degeneration 
and necrosis of hepatocytes, multifoca1 ly;Uphohistio-
cytic pneumonia, Iymphocytic depletion, andmultinu-
cleated giant cell formation,26 The etiologicagent 
responsible for PMWS has been identifiedas a 
circovirus particle named Porcine circovirus-2 (PC:V-2; 
family Circoviridae, genus Circovirus).1.19,2S The PCV-2 
From the Groupe de recherche sur les maladies infectieuses du 
porc (Gagnon, dei Castillo, Music, Harel), the Service de 
diagnostic (Gagnoll, Fontaine; Harel, Tremblay), and the Groupe 
de recherche en pharmacologie animale du Québec (dei Castillo), 
Faculté de médecine vétérinaire, Université de Montréal, St-
Hyacinthe~ Québec, Canada. 
1 Corresponding Author: Carl A. Gagnon, Faculté de'médecine 
vétérinaire, Université de Montréal, 3200 rue Sicotte,'Si-Hya-
cinthe, Québec, Canada, J2S 2M2. 
"stranded ambisense circular DNA genome of about 
1.76 kb in length.2o.J3;41.s4 Viral DNA possesses at least 
3 functional open readingframes (ORFs): ORFI 
encodes the Rep proteins involved in virus. replièa-
tiOll,9.1O.38 ORF2 encpdes the nucleocapsid (Cap)-
protein,42 and ORF3 encodes a protein that induces 
apoptosis and is involved in viral pathogenesis in 
viVO. 3S•36 Today, the clinical expression of PCV-2 
infection inswine is acknowledged to be more complex 
than initiaily established because it canplay a pivotl!l 
rolein .several syndromes, such as porcine dermatitis 
and nephropathysyndrome,. pordne respiratory 'dis, 
ease ,complex, reproductive failure, granulomatous 
enteritis, necrotizing Iyrnphadenitis, exudative epider-
mitis, "and congeriital' tremor.8•27 Consequently, ,.the 
term "Porcille circovirl,ls-associated disease" (PCV AD) 
is now accepte,}: to describe the syndromes in which 
PCV-2 plays a role." . 
At the end of 2004, the swine industry in .the 
province of Quebec in Canada started to experience a 
significantinerease indeath rate related to PCVAD,14 
It washypothesii:~d that this emerging problem was 
caused by thepr,esence of a new type of circulaiiilg 
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